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ABSTRACT
The pace and unpredictability of evolution are critically relevant in a variety of modern challenges: combating drug resistance in
pathogens and cancer, understanding how species respond to environmental perturbations like climate change, and developing
artificial selection approaches for agriculture. Great progress has been made in quantitative modeling of evolution using fitness
landscapes, allowing a degree of prediction for future evolutionary histories. Yet fine-grained control of the speed and the
distributions of these trajectories remains elusive. We propose an approach to achieve this using ideas originally developed in a
completely different context – counterdiabatic driving to control the behavior of quantum states for applications like quantum
computing and manipulating ultra-cold atoms. Implementing these ideas for the first time in a biological context, we show how a
set of external control parameters (i.e. varying drug concentrations / types, temperature, nutrients) can guide the probability
distribution of genotypes in a population along a specified path and time interval. This level of control, allowing empirical
optimization of evolutionary speed and trajectories, has myriad potential applications, from enhancing adaptive therapies for
diseases, to the development of thermotolerant crops in preparation for climate change, to accelerating bioengineering methods
built on evolutionary models, like directed evolution of biomolecules.
The quest to control evolutionary processes in areas like agriculture and medicine predates our understanding
of evolution itself. Recent years have seen growing research efforts toward this goal, driven by rapid progress in
quantifying genetic changes across a population1–3 as well as a global rise in challenging problems like therapeutic
drug resistance4–6. New approaches that have arisen in response include prospective therapies that steer evolution
of pathogens toward maximized drug sensitivity7,8, typically requiring multiple rounds of selective pressures and
subsequent evolution under them. Since we cannot predict the exact progression of mutations that occur in the
course of the treatment, the best we can hope for is to achieve control over probability distributions of evolutionary
outcomes. However, our lack of precise control over the timing of these outcomes poses a major practical impediment
to engineering the course of evolution. This naturally raises a question: Rather than being at the mercy of evolution’s
unpredictability and pace, what if we could simultaneously control the speed and the distribution of genotypes over
time?
Controlling an inherently stochastic process like evolution has close parallels to problems in other disciplines.
Quantum information protocols crucially depend on coherent control over the time evolution of quantum states
under external driving9,10, in many cases requiring that a system remain in an instantaneous ground state of a
time-varying Hamiltonian in applications like cold atom transport11 and quantum adiabatic computation12. The
adiabatic theorem of quantum mechanics facilitates such control when the driving is infinitely slow, but over finite
time intervals control becomes more challenging, because fast driving can induce random transitions to undesirable
excited states. Overcoming this challenge—developing fast processes that mimic the perfect control of infinitely
slow ones—has led to a whole subfield of techniques called “shortcuts to adiabaticity”13–18. One such method
in particular, known as transitionless, or counterdiabatic (CD) driving, involves adding an auxiliary control field
to the system to inhibit transitions to excited states19–21. Intriguingly, the utility of CD driving is not limited
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to quantum contexts: requiring a quantum system to maintain an instantaneous ground state under driving is
mathematically analogous to demanding a classical stochastic system remains in an instantaneous equilibrium
state as external control parameters are changed22,23. Extending CD driving ideas to the classical realm has
already led to proof-of-concept demonstrations of accelerated equilibration in optical tweezer24 and atomic force
microscope25 experimental frameworks, and is closely related to optimal, finite-time control problems in stochastic
thermodynamics26,27.
Here we demonstrate the first biological application of CD driving, by using it to control the distribution of
genotypes in a Wright-Fisher model28 describing evolution in a population of organisms. The auxiliary CD control
field (implemented for example through varying drug concentrations or other external parameters that affect fitness)
allows us to shepherd the system through a chosen sequence of genotype distributions, moving from one evolutionary
equilibrium state to another in finite time. We validate the CD theory through numerical simulations using an
agent-based model of evolving unicellular populations, focusing on a system where sixteen possible genotypes compete
via a drug dose-dependent fitness landscape derived from experimental measurements.
1 Theory
1.1 Evolutionary model
We develop our CD driving theory in the framework of a Wright-Fisher diffusion model for the evolution of genotype
frequencies in a population (see Methods for details). Let us consider M possible genotypes, where the ith genotype
comprises a fraction xi of a population. Since
∑M
i=1xi = 1, we can describe the state of the system through M −1
independent values of xi, or equivalently through a frequency vector x= (x1, . . . ,xM−1). Without loss of generality,
we will take the Mth genotype to be the reference (the “wild type”) with respect to which the relative fitnesses of
the others will be defined. Let 1 +si be the relative fitness of genotype i= 1, . . . ,M −1 compared to the wild type,
where si is a selection coefficient, defining the ith component of a vector s. We assume fitnesses are influenced by
some time-dependent control parameter λ(t), which we write as a scalar quantity, though it could in principle be a
vector, reflecting a set of control parameters. These parameters could involve any environmental quantity amenable
to external control: in the examples below we consider the concentration of a single drug applied to a population of
unicellular organisms. However we could have more complicated drug protocols (switching between multiple drugs)7
or other perturbations in fitness secondary to microenvironmental change (e.g. nutrient or oxygenation levels).
Our control protocol λ(t) from initial time t0 to final time tf defines a trajectory of the selection coefficient vector,
s
(
λ(t)
)
, shown schematically in Fig. 1A. Our population thus evolves under a time-dependent fitness landscape, or
so-called “seascape”29. Note that all time variables, unless otherwise noted, are taken to be in units of Wright-Fisher
generations.
For simplicity, the total population is assumed to be fixed at a value N , corresponding to a scenario where the
system stays at a time-independent carrying capacity over the time interval of interest. (Our approach is easily
generalized to more complicated cases with time-dependent N(t), as shown in the Supplementary Information [SI]).
The final quantity characterizing the dynamics is an M ×M dimensional mutation rate matrix m, where each
off-diagonal entry mβα represents the mutation probability (per generation) from the αth to the βth genotype. For
later convenience, the αth diagonal entry of m is defined as the opposite of the total mutation rate out of that
genotype, mαα ≡ −
∑
β 6=αmβα. As in the case of N , we assume the matrix m is time-independent, though this
assumption can be relaxed.
1.2 Driving the genotype frequency distribution
Given the system described above, we focus on p(x, t), the probability to find genotype frequencies x at time t,
calculated over an ensemble of possible evolutionary trajectories. The dynamics of this probability for the WF model
can be described to an excellent approximation through a Fokker-Planck equation:
∂tp(x, t) = L
(
λ(t)
)
p(x, t), (1)
where ∂t ≡ ∂/∂t and L
(
λ(t)
)
is a differential operator, acting on functions of x, described in the Methods. This
operator involves N , m, and s
(
λ(t)
)
, and we highlight the dependence on λ(t). In setting up the analogy to
driving in quantum mechanics, Eq. (1) corresponds to the Schrödinger equation, with p(x, t) playing the role of
the wavefunction and L(λ(t)) the time-dependent Hamiltonian operator. The full analogy between quantum and
evolutionary dynamics is described in more detail in Box 1 of the Methods. Though for our purposes we only employ
this analogy qualitatively, in fact there exists in certain cases an explicit mapping from the Fokker-Planck to the
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Schrödinger equation (though not vice versa)30–32. For a particular value of the control parameter λ, the analogue of
the quantum ground state wavefunction is the eigenfunction ρ(x;λ) with eigenvalue zero, the solution of the equation
L(λ)ρ(x;λ) = 0. (2)
In the evolutionary context, ρ(x;λ) has an additional meaning with no direct quantum correspondence: it is the
equilibrium probability distribution of genotypes. If one fixes the control parameter λ(t) = λ, the distribution p(x, t)
obeying Eq. (1) will approach ρ(x;λ) in the limit t→∞.
Consider the following control protocol, where we start at one control parameter value, λ(t) = λ0 for t≤ t0, and
finish at another value, λ(t) = λf for t≥ tf , with some arbitrary driving function λ(t) in the interval t0 < t < tf . We
assume the system starts in one equilibrium distribution, p(x, t0) = ρ(x;λ0), and we know that it will eventually
end at a new equilibrium, p(x, t)→ ρ(x;λf ) for t tf . But what happens at intermediate times? If λ(t) changes
infinitesimally slowly during the driving (and hence tf →∞) then the system would remain at each moment in the
corresponding instantaneous equilibrium (IE) distribution, p(x, t) = ρ
(
x;λ(t)
)
for all t. This result, derived in the SI,
is the analogue of the quantum adiabatic theorem33 applied to the ground state: for a time-dependent Hamiltonian
that changes extremely slowly, a quantum system that starts in the ground state of the Hamiltonian always remains
in the same instantaneous ground state (assuming that at all times there is a gap between the ground state energy
and the rest of the energy spectrum). Fig. 1B shows schematic snaphsots of ρ
(
x;λ(t)
)
at three times, with the
control parameter shifting them across the genotype frequency space.
When the driving occurs over finite times (tf <∞), the above results break down: p(x, t) 6= ρ
(
x;λ(t)
)
for
0< t < tf , but is instead a linear combination of many instantaneous eigenfunctions of the Fokker-Planck operator,
just as the corresponding quantum system under faster driving will generically evolve into a superposition of the
instantaneous ground state and excited states. This will manifest itself as a lag, with p(x, t) moving towards but
not able to catch up with ρ
(
x;λ(t)
)
, as illustrated in Fig. 1C. For t > tf , once λ(t) stops changing, the system will
eventually settle into equilibrium at ρ(x;λf ) in the long time limit.
1.3 Control and counterdiabatic driving
This lag can be an obstacle if one wants to control the evolution of the system over finite time intervals. Since
evolutionary trajectories are stochastic, we cannot necessarily guarantee that the system starts and ends at precise
genotype frequencies, but we can attempt to specify initial and final target frequency distributions. At the end
of the driving t = tf , we would like our system to arrive at the target distribution, and then stay there as long
as the control parameter is fixed. In this way we complete one stage of the control protocol, and have a known
starting point for the next stage, since in practice we could imagine the interval t0 < t < tf as just one step of a
multi-stage protocol involving distinct interventions (i.e. a sequence of different drugs). Completing each stage as
quickly as possible, while accurately hitting each target, would for example be a crucial prerequisite to translating
certain evolutionary medicine approaches to clinical settings (see SI Sec. H for a fuller discussion). Thus, if we were
enumerating the characteristics of an ideal control mechanism, at the very least it should be able to drive the system
from one equilibrium distribution, p(x, t0) = ρ(x;λ0), to another, p(x, tf ) = ρ(x;λf ), over a finite time tf − t0.
In the context of quantum adiabatic computing12, the typical focus is on the initial ground state (which has to
be easy to realize experimentally) and the final ground state (since it encodes the solution to the computational
problem). In the evolutionary case, we can imagine additional desired characteristics for our driving, beyond
the start and end-point distributions. There are many ways to go from an initial fitness landscape, s(λ0), to a
final fitness landscape, s(λf ), corresponding to different possible trajectories in the selection coefficient space of
Fig. 1A that share initial and final values. Depending on how we empirically implement the control, many of these
trajectories may be physically inaccessible. But among the remaining set of realizable trajectories, some may be
more desirable than others (i.e. have different evolutionary consequences34, or trade-offs35). Each trajectory defines
a continuous sequence of IE distributions ρ
(
x;λ(t)
)
, and for each distribution there is a mean genotype frequency
x
(
λ(t)
)
, illustrated in the lower half of Fig. 1B. We may, for example, want protocols that minimize the chances of
our system visiting certain problematic genotypes: in practice this could translate to demanding that the curve
x
(
λ(t)
)
for t0 < t < tf stays far away from certain regions of the genotype frequency space. This in turn restricts
the s
(
λ(t)
)
trajectories and hence the protocols λ(t) of practical interest. In simpler terms, we would ideally like to
control not just the distributions at the beginning and end of the driving, but also if possible along the way.
We formulate this ideal control problem in the following way: we demand that p(x, t) = ρ
(
x;λ(t)
)
for some chosen
control protocol λ(t) between t0 < t < tf . The protocol λ(t) is determined with the above considerations in mind,
and thus defines a particular path through the space of genotype frequency distributions over which we would like to
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Figure 1. (A) A schematic illustration for three genotypes (M = 3) showing the trajectory of the selection
coefficient vector s
(
λ(t)
)
as a function of a time-varying control parameter λ(t) depicted in the bottom of the panel.
This represents the fitness “seascape” under which the population evolves during driving. Three time points are
highlighted: the initial time t0, an intermediate time t1, and the final time tf , where the corresponding control
parameter values are λ0, λ1, and λf . The amplitude of the control parameter along the trajectory is represented
through a color gradient. (B) The instantaneous equilibrium (IE) distribution of genotypes ρ
(
x;λ(t)
)
for the three
highlighted values of the control parameter from panel A. These distributions are probability densities on the 2D
simplex defined by x1 +x2 ≤ 1 and x1, x2 ≥ 0. In the lower part of the panel we show the curve of mean IE
genotype frequencies x
(
λ(t)
)
. (C) For driving over finite times, the actual distribution of genotypes p(x, t) will
generally lag behind the IE distribution while the control parameter is changing. Thus at tf the distribution p(x, tf )
is still far from ρ(x;λf ), and will only catch up with it at times t tf as the system re-equilibrates.
guide our system. Clearly we will not achieve success by just directly implementing λ(t), since p(x, t) obeying Eq. (1)
will generally lag behind ρ
(
x;λ(t)
)36. The resolution of this problem in the quantum case through CD driving is to
add a specially constructed auxiliary time-dependent Hamiltonian to the original Hamiltonian19–21. For a specific
choice of this auxiliary Hamiltonian, we can guarantee that our new system always remains in the instantaneous
ground state of the original Hamiltonian. The evolutionary analogue of CD is to replace the Fokker-Planck operator
L(λ(t)) in Eq. (1) with a different operator L˜(λ(t), .λ(t)), which depends on both λ(t) and its time derivative.
λ(t)≡ dλ(t)/dt. This CD operator satisfies
∂tρ
(
x;λ(t)
)
= L˜(λ(t), .λ(t))ρ(x;λ(t)). (3)
Thus by construction, p(x, t) = ρ
(
x;λ(t)
)
is a solution to the Fokker-Planck equation with the new operator.
Additionally, to be consistent with the slow adiabatic driving limit discussed above, L˜(λ(t),0) = L(λ(t)), so we
recover the original Fokker-Planck operator when the speed of driving
.
λ(t)→ 0 and tf →∞.
Of course defining L˜(λ(t), .λ(t)) in this way is the easy part: figuring out how to implement a new control protocol
to realize L˜(λ(t), .λ(t)) is more challenging. In the Methods, we show how the most general solution to go from L to
L˜ is to replace the original selection coefficient trajectory s(λ(t)) with a frequency-dependent version, s˜(x;λ(t), .λ(t)).
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Implementing a particular frequency dependent fitness seascape is a degree of control that is generally impossible
in realistic scenarios. Fortunately, we show that in one important parameter regime the CD seascape becomes
approximately frequency-independent, s˜
(
x;λ(t),
.
λ(t)
)≈ s˜(λ(t), .λ(t)). This occurs in the large population, frequent
mutation regime: if the typical mutation rate scale is µ, meaning mβα ∼O(µ) for all nonzero mutation rates where
α 6= β, then this corresponds to µN  1, N  137–40. In this regime multiple genotypes can generally coexist in
the population at equilibrium (though one may be quite dominant), which is particularly relevant for pathogenic
populations, especially ones spreading through space41–43. Remarkably, there is a simple analytical expression that
provides an excellent approximation to s˜
(
λ(t),
.
λ(t)
)
in this case:
s˜i
(
λ(t),
.
λ(t)
)≈ si(λ(t))+ d
dt
ln
xi
(
λ(t)
)
xM
(
λ(t)
) , i= 1, . . . ,M −1, (4)
where xM
(
λ(t)
) ≡ 1−∑M−1i=1 xi(λ(t)). We see that the new selection coefficient protocol is defined through the
target mean genotype frequency trajectory x
(
λ(t)
)
, and reduces to the original protocol when
.
λ(t)→ 0. Moreover,
as we show in the examples below for specific systems, Eq. (4) can at least in certain cases be implemented through
physically realistic manipulations of the environment, like time-varying drug dosages. While we focus on the frequent
mutation regime in the current work, the applicability of CD ideas is not limited to just this regime: for the opposite
case of infrequent mutations, µN  1, where the evolutionary dynamics can be modeled as a sequence of mutant
fixations, one can also formulate a CD theory based on a discrete Markov state description44 (see our follow-up
article45).
2 Results
2.1 Two genotypes
The simplest example of our CD theory is for a two genotype (M = 2) system, where the dynamics are one
dimensional, described by a single frequency x1 and selection coefficient s1(λ(t)). As shown in the Methods, Eq. (4)
in this case can be evaluated analytically. To illustrate driving, we assume a control protocol λ(t) such that the
selection coefficient increases according to a smooth ramp (the original protocol in Fig. 2B). This starts from zero at
t0 (both genotypes have equal fitness) and increases until reaching a plateau at a final selection coefficient that favors
genotype 1. Fig. 2A shows p(x1, t) from a numerical solution of Eq. (1) using this protocol, compared against the IE
distribution ρ
(
x1;λ(t)
)
, solved using Eq. (2), at three time snapshots. To validate the Fokker-Planck approach, we
also designed an agent-based model (ABM), described in the Methods section 4.5, which simulates the individual
life trajectories of an evolving population of cells. Because there exists a mapping between the parameters of the
ABM and the equivalent Fokker-Planck equation (Methods section 4.5.3), one can directly compare the p(x1, t)
results from the ABM simulations (circles) to the Fokker-Planck numerical solution of Eq. (1) (curves), which show
excellent agreement. In the absence of CD driving, as expected, p(x1, t) lags behind ρ
(
x1;λ(t)
)
, with the latter
shifting rapidly to larger x1 frequencies as the fitness of genotype 1 increases.
To eliminate this lag, we implement the alternative selection coefficient trajectory of Eq. (20). Fig. 2B shows a
comparison between s˜1
(
λ(t),
.
λ(t)
)
and the original s1
(
λ(t)
)
. We see that the CD intervention requires a transient
overshoot of the selection coefficient during the driving, nudging p(x1, t) to keep up with ρ
(
x1;λ(t)
)
. Panel C
shows the same snapshots as in panel A, but now with CD driving: we see the actual and IE distributions nearly
perfectly overlap at all times. To quantify the effectiveness of the CD protocol, we measure the degree of overlap
through the Kullback-Leibler (KL) divergence36,46, defined for any two probability distributions p(x) and q(x)
as DKL(p||q) =
∫
dxp(x) log2
(
p(x)/q(x)
)
. Expressed in bits, the KL divergence is always ≥ 0, and equals 0 for
identical distributions. Panel D shows DKL(ρ||p) for both the original and CD protocols, with the latter dramatically
reducing the divergence across the time interval of driving.
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Figure 2. Results for two genotypes. (A,C) We plot three time snapshots of the actual probability
distribution p(x1, t) versus the IE distribution ρ
(
x1;λ(t)
)
for driving with the original control protocol (A) and
with the CD driving protocol (C), where x1 is the fraction of genotype 1 in the population. Solid red curves are
numerical solutions of the Fokker-Planck Eq. (1) for p(x1, t), red circles are agent-based simulations. Without CD
driving, the actual distribution always lags behind the IE. B) The selection coefficient trajectory s1 for the original
control protocol (dark blue) versus the corresponding CD prescription (green) s˜1 from Eq. (20). The three snapshot
times (50, 100, 150 generations) are indicated by triangles. (D) Kullback-Leibler divergence between actual and IE
distributions versus time, with and without CD driving, calculated using the numerical Fokker-Planck solution.
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2.2 Multiple genotypes via agent-based modeling
The ABM simulations also allow us to test the CD theory in more complex scenarios. To this end we considered a
system with 16 genotypes (4 alleles), with selection coefficients based on a well characterized experimental system:
the fitness effects of the anti-malarial drug pyrimethamine at varying concentrations on all possible combinations of
four different drug-resistance alleles2,3. Our control parameter λ(t) is the drug concentration, and we implement
the seascape by increasing the drug over time (after an initial equilibration period), eventually saturating at a
concentration of 10−4 M (the protocol labeled “original” in Fig. 3E). With our choice of simulation parameters
(Methods section 4.5.2), a number of the genotypes have sufficient resistance to survive even at higher drug dosages,
so the overall population remains at carrying capacity. What changes as the dosage increases is the distribution of
genotypes. Fig. 3A and 3B show the results in the absence of CD driving, with each genotype labeled by a 4-digit
binary sequence. The population goes from being dominated by 1110 (with smaller fractions of other genotypes)
to eventually becoming dominated by 1111. However there is a dramatic lag behind the IE distribution, taking
more than 1500 generations to resolve. This is quantified in the KL divergence DKL(ρ||p) in Fig. 3F, which rapidly
increases by 5 orders of magnitude as the drug ramp starts showing its effects (around generation 500). Equilibration
to the higher drug dosages brings the divergence back down over time, but it only achieves relatively small amplitudes
after generation 2000. Note that the scale of the KL divergences for 15-dimensional probability distributions is larger
than for the 1D example in the previous section: this reflects both the greater sensitivity of the KL measure to
small discrepancies in a 15-dimensional space, as well as the fact that distributions estimated from an ensemble
of simulations (1000 indepedent runs in this case) will always have a degree of sampling error. Thus it is more
instructive to look at the relative change of the KL with driving rather than the absolute magnitudes.
To reduce the lag through CD driving, one should in principle implement the selection coefficients according
to Eq. (4). However this involves guiding the system along a fitness trajectory in a 15-dimensional space, and in
this case we have a single tuning knob (the concentration of pyrimethamine) to perturb fitnesses. In such scenarios
one then looks at the closest approximation to CD driving that can be achieved with the experimentally accessible
control parameters. In this particular case the genotypes which dominate the population at small and large drug
concentrations are 1110 (i= 15) and the wild-type 1111 (i= 16), so the selection coefficient s15 which encodes their
fitness relative to each other plays the most important role in the dynamics. We thus choose a CD drug dosage
by numerically solving for the concentration that most closely approximates the i = 15 component of Eq. (4) at
each time. Because in real-world scenarios there will be limits on the maximum allowable dosage, we constrain the
CD concentrations to be below a certain cutoff. The approximation described here, where two different genotypes
dominate at different times during the driving, is just a special case of a more general approximation approach where
we seek to achieve the closest possible protocol to the one described by Eq. (4), given the experimental constraints.
In SI Sec. I we illustrate how this general strategy works in two additional 16-genotype seascape examples (including
the empirical seascape for the drug cycloguanil2) where more than two genotypes dominate during driving.
Fig. 3E shows CD drug protocols with three different cutoffs: 10−2, 10−3, 5×10−4 M (all within the experimentally
measured dosage range). The higher the cutoff, the better the approximation to CD driving. We can directly
quantify the overall reduction in lag time ∆t due to CD from the KL divergence results of Fig. 3F, as explained in
Methods section 4.5.4. For a cutoff of 10−2 M the lag is reduced by ∆t= 1210 generations. Notably, though the
approximation is based on the top two genotypes (1110 and 1111), it reduces the lag time across the board for all
genotypes (see Fig. 3C for four representative genotype trajectories at 10−2 M cutoff, with other genotypes shown in
the snapshots of Fig. 3D). This is because driving of the top two also entrains the dynamics of the subdominant
genotypes whose populations are sustained by mutations out of and into the dominant ones. Even with the more
restrictive constraint of 5×10−4 M there is still a substantial benefit, with the lag reduced by ∆t= 656 generations.
This highlights the robustness of the CD approach: even if one cannot implement the solution of Eq. (4) exactly, we
can still arrive at the target distribution faster through an approximate CD protocol.
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Figure 3. CD driving eliminates evolutionary lag in 16 genotype simulation. (A,D) We plot three
snapshots of our evolving agent-based population model without (A) and with (D) CD driving. Each of the three
16 genotype (4 binary alleles) hypercubic graphs (“tesseracts”) has vertices with log-scaled radii representing the
fraction of each genotype in the total population at a given time. Orange is the actual fraction, blue the IE fraction,
and the overlap appears purple. The CD driving in this case is implemented approximately through a drug dosage
protocol (panel E) with cutoff 10−2 M. (B,C) Corresponding sample simulation trajectories (solid lines) versus IE
expectation (dashed lines) for the fraction of 4 representative genotypes without (B) and with (C) CD driving. The
latter significantly reduces the nearly 1500 generation lag. (E) Original drug protocol versus the CD protocol with
different possible dosage cutoffs. (F) Kullback-Leibler divergence between actual and IE distributions versus time,
with and without CD driving. For the latter, increasing the dosage cutoff value makes the protocol more closely
approximate the true CD solution, and hence decreases the divergence.
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3 Discussion and Conclusions
Our demonstration of the CD driving approach in a population model with empirically-derived drug-dependent
fitnesses shows that we can accelerate evolution toward a target distribution in silico. As new technologies
progressively allow us to assemble ever more extensive fitness landscapes for various organisms as a function of
external perturbations like drugs1–3, the next step is implementing CD driving in the laboratory. This would be
a necessary milestone on the path to a range of potential applications (the latter discussed in more detail in SI
Sec. H). Thus it is worth considering the challenges and potential workarounds that will be involved in experimental
applications.
One salient issue is the range of control parameters available in laboratory settings. Our examples have focused
on the simplest cases of one-dimensional control, but to access the full power of the CD approach presented here
we should explore a richer parameter space: not only single drugs, but combinations, along with varying nutrients,
metabolites, oxygen levels, osmotic pressure, and temperature. The eventual goal would be to have for every system
a library of well-characterized interventions that could be applied in tandem, allowing us the flexibility to map
out desired target trajectories through a multidimensional fitness landscape. In other words for a given system we
would have access to a selection coefficient function s(λ(t)), where λ(t) = (λ1(t),λ2(t), . . .) is a multidimensional
vector of control parameters at time t: λ1(t) the concentration of one drug, λ2(t) the concentration of another drug
(or nutrient), and so on. An interesting future extension of the theory would also investigate the role of spatial
environments and restrictions as a potential control knob. More generally, one could explore how fundamental
differences among fitness landscapes (i.e. the difficulties in reaching local optima in so-called “hard” landscapes68)
influences the types of interventions needed to achieve driving and their effectiveness.
Even given accurately measured fitnesses, one might be hampered by imperfect estimation of other system
parameters, for example mutation rates. To determine how large the margin for error is, we tested the CD driving
prescription calculated using incorrect mutation rates, varying the degree of discrepancy over two orders of magnitude
(see SI for details). While such discrepancies do reduce the efficacy of CD driving, leading to deviations between
actual and IE distributions at intermediate times, populations driven with an incorrect protocol still reached the
target distribution faster than in the absence of driving. As in the case of the dosage cutoff discussed above, the CD
approach has a degree of robustness to errors in the protocol, which increases its chances of success in real-world
settings.
But what if we lacked measurements of the underlying fitness seascape? Interestingly, there might still be some
utility of the CD method even in this case. We could first do a preliminary quasi-adiabatic experimental trial: vary
external parameter(s) λ extremely gradually, and use sequencing at regularly spaced intervals to determine the
quasi-equilibrium mean genotype fractions xi(λ) as a function of λ. If we now wanted to guide the system through
the same sequence of evolutionary distributions but much faster, we have enough information to approximately
evaluate the CD perturbation in Eq. (4), which just depends on xi(λ) and the rate
.
λ(t) that we would like to
implement. So at the very least the CD prescription could be estimated, providing a blueprint, and the remaining
challenge would be figuring out what combination of external perturbations would yield the right sorts of fitness
perturbations to achieve CD driving.
“Nothing makes sense in biology except in the light of evolution” is an oft-quoted maxim which was the title of a
1973 essay by Theodosius Dobzhansky48. However evolution is not just the fundamental paradigm through which
we can understand living systems, but also a framework by which we can shape and redesign nature at a variety of
scales: from engineering new proteins49 and aptamers50,51 to combating drug resistance in pathogens and cancer7
to the development of crops that can withstand climate stress52. In all its manifestations, natural and synthetic,
evolution is a stochastic process that occurs across a wide swath of timescales. Our work represents a significant step
toward more precise control of both the distribution of possible outcomes and the timing of this fundamental process.
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4 Methods
Box 1: Analogies between quantum physics and evolutionary dynamics
Here we summarize the connections between quantum and evolutionary concepts used in our theory. Each
numbered item in the quantum column on the left has its analogue in the evolutionary column on the right.
Quantum physics
1. Wavefunction: describes the state of a quan-
tum system. For a simple quantum particle in a
spatial region described by coordinates x, this
is a function ψ(x, t) whose squared amplitude
|ψ(x, t)|2 is the probability density of finding
the particle at x at time t.
2. Hamiltonian operator: a differential op-
erator H(λ(t)) depending on control param-
eters λ(t) defined below. It describes how
the wavefunction changes in time through
the time-dependent Schrödinger equa-
tion, i}∂tψ(x, t) =H(λ(t))ψ(x, t), where } is
the reduced Planck constant. H(λ(t)) involves
terms that correspond to the kinetic and poten-
tial energies of the quantum particle.
3. Control parameters: a set of parameters λ(t)
that can be manipulated over time by an ex-
perimentalist. These parameters modify the
kinetic/potential energy terms in the Hamilto-
nian, and thus influence the quantum dynamics.
An example of this would be the magnitude of
an externally applied electromagnetic field.
4. Ground state: the lowest energy state
of a quantum system. In general, for
a Hamiltonian H(λ) and given parameter
values λ, the energy states (labeled by
n = 0,1,2, . . .) correspond to solutions of
the time-independent Schrödinger equation:
H(λ)ψn(x;λ) = En(λ)ψn(x;λ). Here En(λ)
and ψn(x;λ) are the energy and wavefunction
respectively of the nth state. The energies
E0 < E1 < · · · , and the ground state corre-
sponds to n= 0. If λ is fixed, a system whose
wavefunction is ψn(x;λ) will be stationary, with
its wavefunction not changing in time.
5. Adiabatic theorem: if we start in the nth
energy state, ψ(x, t= 0) = ψn(x;λ(0)) for some
initial control parameters λ(0), and then vary
λ(t) infinitesimally slowly (adiabatically) the
theorem states that the wavefunction at later
times remains in nth energy state corresponding
to the instantaneous value of the parameters,
ψ(x, t) = ψn(x;λ(t)). This is true so long as
there is always a nonzero difference between
En(λ(t)) and any Em(λ(t)) for m 6= n at all t.
Evolutionary dynamics
1. Genotype probability distribution: the
distribution p(x, t) of genetic variants (geno-
types) in a population of organisms at time t,
where x is a vector of genotype fractions.
2. Fokker-Planck operator: a differential op-
erator L(λ(t)) depending on control param-
eters λ(t) defined below. It describes how
the genotype probability p(x, t) changes in
time through the Fokker-Planck equation,
∂tp(x, t) = L(λ(t))p(x, t). The full form of
L(λ(t)) [Eqs. (5)-(7)] involves terms that de-
scribe the mean change in genotype fractions
due to mutations and selection, as well as the
effects of genetic drift.
3. Control parameters: a set of parameters λ(t)
that can be manipulated over time by an ex-
perimentalist. These parameters modify geno-
type fitnesses, and hence influence evolutionary
dynamics through the selection terms in the
Fokker-Planck operator. An example would be
the concentration of a drug applied to a mi-
crobial population, where different genotypes
exhibit different degrees of resistance against
the drug depending on the concentration.
4. Equilibrium state: for a given set of pa-
rameter values λ, this is the genotype prob-
ability ρ(x;λ) which would remain unchanged
in time (stationary) during evolutionary dy-
namics under fixed λ. In general a Fokker-
Planck operator L(λ) has a set of eigenfunc-
tions ψn(x;λ) and eigenvalues −κn(λ)≤ 0 for
n= 0,1,2 . . . defined through the following equa-
tion: L(λ)ψn(x;λ) = −κn(λ)ψn(x;λ). The
equilibrium state corresponds to n = 0, with
eigenvalue −κ0(λ) = 0 and ρ(x;λ)≡ ψ0(x;λ).
5. Adiabatic theorem: If we start at equilib-
rium p(x, t = 0) = ρ(x;λ(0)) for some initial
control parameters λ(0), and then vary λ(t) in-
finitesimally slowly (adiabatically) the theorem
(derived in SI Sec. A) states that at later times
we will always remain in the equilibrium state
corresponding to the instantaneous value of the
parameters, p(x, t) = ρ(x;λ(t)).
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4.1 Fokker-Planck description of Wright-Fisher evolutionary model
The underlying evolutionary dynamics of our model are based on the canonical haploid Wright-Fisher (WF) model
with mutation and selection, and we adopt the formalism of recent approaches29,53 that generalized Kimura’s
original two-allele diffusion theory54 to the case of multiple genotypes. A convenient feature of the WF formalism is
that other, more detailed descriptions of the population dynamics (for example agent-based models that track the
life histories of individual organisms) can often be mapped onto an effective WF form, as we illustrate below.
The starting point of the Fokker-Planck diffusion approximation29,53,54 for evolutionary population dynamics is
the assumption that genotype frequencies change only by small amounts in each generation. Thus we can take the
genotype frequency vector x to be a continuous variable that follows a stochastic trajectory. The key quantities
describing these stochastic dynamics are the lowest order moments of δx, the change in genotype frequency per
generation. We will denote the mean of the change in the ith genotype, δxi, taken over the ensemble of possible
trajectories, as vi
(
x;λ(t)
)≡ 〈δxi〉. Note that in general vi(x;λ(t)) will be a function of the genotype frequencies x
at the current time step, and also have a dependence on the control parameter λ(t) through the selection coefficient
vector s
(
λ(t)
)
(which influences 〈δxi〉).
In non-evolutionary contexts vi
(
x;λ(t)
)
is called the drift function, but here we will call it a velocity function to
avoid confusion with genetic drift. Similarly we will introduce an (M −1)× (M −1) diffusivity matrix Dij(x) to
describe the covariance of the genotype changes, defined through 2Dij(x)≡ 〈δxiδxj〉−〈δxi〉〈δxj〉. As shown in the
SI, to lowest order approximation Dij(x) is independent of s
(
λ(t)
)
, and hence is not an explicit function of λ(t). If
we are interested in the dynamics on time scales much larger than a single generation, the probability p(x, t) to
observe a genotype state x at time t obeys a multivariate Fokker-Planck equation55,
∂tp(x, t) =−∂i
(
vi
(
x;λ(t)
)
p(x, t)
)
+∂i∂j
(
Dij(x)p(x, t)
)
≡ L(λ(t))p(x, t), (5)
where ∂t ≡ ∂/∂t and ∂i ≡ ∂/∂xi. Note that we use Einstein summation notation, where repeated indices are summed
over, and furthermore designate Greek indices to range from 1 to M while Roman indices range from 1 to M −1.
So for example the term ∂i∂j
(
Dij(x)p(x, t)
)≡∑M−1i=1 ∑M−1j=1 ∂i∂j(Dij(x)p(x, t)). The right-hand-side of Eq. (5)
defines the Fokker-Planck differential operator L(λ(t)) in main text Eq. (1). In order to correspond to genotype
fractions, the vectors x have to lie in the (M −1)-dimensional simplex ∆ defined by the conditions xi ≥ 0 for all i
and
∑M−1
j=1 xj ≤ 1. If x ∈∆, then the wild type fraction xM = 1−
∑M−1
j=1 xj lies between 0 and 1. Normalization of
p(x, t) takes the form
∫
∆ dxp(x, t) = 1, where the integral is over the volume of the simplex ∆.
To complete the description of the model, we need expressions for the functions vi
(
x;λ(t)
)
and Dij(x). Given a
Wright-Fisher evolutionary model, these take the following form (see SI for a detailed derivation):
vi(x;λ(t)) =miµxµ+gij(x)sj(λ(t)), Dij(x, t) =
gij(x)
2N , (6)
where m is the M ×M mutation rate matrix defined in the main text, and g(x) is an (M −1)× (M −1) matrix
with elements given by
gij(x)≡
{
−xixj i 6= j
xi(1−xi) i= j, no sum over i
. (7)
4.2 Instantaneous equilibrium distributions
The instantaneous equilibrium (IE) distribution ρ(x;λ(t)) is defined through main text Eq. (2), L(λ(t))ρ(x;λ(t)) = 0.
Because we evaluate the effectiveness of our driving by comparing the actual distribution p(x, t) to the IE distribution,
it is useful to know the form of ρ(x;λ(t)). Unfortunately it is generally not possible to find an IE analytical expression,
except in some specific cases29,53. The two genotype system (M = 2) is one example where an exact solution is
known. It has a form analogous to the Boltzmann distribution of statistical physics29,53,
ρ(x;λ(t)) = e
−Φ(x;λ(t))
Z(λ(t)) , (8)
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where Φ(x;λ(t)) is an effective “potential” given by
Φ(x;λ(t)) =−2N (m12 logx1 +m21 log(1−x1) +s1(λ(t))x1) + logdetg(x) (9)
and Z(λ(t)) is a normalization constant.
To estimate the IE distribution for general M , we take advantage of the large population, frequent mutation
regime: mβα ∼O(µ) for all nonzero matrix entries where α 6= β, with µN  1, N  1. In this case we know that
ρ(x;λ(t)) is approximately a multivariate normal distribution of the form
ρ(x;λ(t))≈
(
(2pi)M−1 detΣ(λ(t))
)−1/2
exp
(
−12
(
xi−xi(λ(t))
)
Σ−1ij (λ(t))
(
xj−xj(λ(t))
))
. (10)
Here xi(λ) =
∫
∆ dxxiρ(x;λ) is the ith mean genotype fraction for the IE distribution, and Σ
−1(λ) is the inverse of
the covariance matrix Σ(λ) for this distribution. The latter has entries Σij ≡ xixj−xixj . In order to make practical
use of Eq. (10), we need a method to estimate xi(λ) and Σ(λ). As shown in the SI, this can be done through an
approximate numerical solution to a set of exact equations involving the moments of ρ(x;λ).
4.3 Counterdiabatic driving protocol
To implement CD driving, we need to solve for the CD Fokker-Planck operator L˜(λ(t), .λ(t)) that satisfies main text
Eq. (3). We posit that L˜ should be in the Fokker-Planck form of Eq. (5), but with some CD version of the selection
coefficient, s˜
(
x;λ(t),
.
λ(t)
)
, instead of the original s(λ(t)). The necessary perturbation to the fitness seascape to
achieve CD driving, δs˜
(
x;λ(t),
.
λ(t)) ≡ s˜(x;λ(t), .λ(t))− s(λ(t)), we take for now to be frequency-dependent for
generality. Thus main text Eq. (3) takes the form
∂tρ
(
x;λ(t)
)
= L˜(λ(t), .λ(t))ρ(x;λ(t))
=−∂i
(
v˜i
(
x;λ(t),
.
λ(t)
)
ρ
(
x;λ(t)
))
+∂i∂j
(
Dij(x)ρ
(
x;λ(t)
)) (11)
with a modified velocity function:
v˜i
(
x;λ(t),
.
λ(t)
)
=miµxµ+gij(x)s˜j
(
x;λ(t),
.
λ(t)
)
= vi
(
x;λ(t)
)
+gij(x)δs˜j
(
x;λ(t),
.
λ(t)
)
.
(12)
Using the fact that L(λ(t))ρ(x;λ(t))= 0, since ρ(x;λ(t)) is the IE distribution of the original operator L, we can
rewrite Eq. (11) as
∂tρ
(
x;λ(t)
)
=−∂i
(
ρ
(
x;λ(t)
)
gij(x)δs˜j
(
x;λ(t),
.
λ(t)
))
≡−∂iJi.
(13)
where Ji ≡ ρ
(
x;λ(t)
)
gij(x)δs˜j
(
x;λ(t),
.
λ(t)
)
is a probability current. In this form Eq. (13) looks like a continuity
equation, describing the local transport of probability density due to the current field J . In order for this equation
to conserve total probability over the simplex ∆, we also require the condition that Jini = 0 at any point on
the boundary of the simplex, where the vector n is normal to the boundary at the point. The perturbation
δs˜
(
x;λ(t),
.
λ(t)) that satisfies Eq. (13) and the boundary condition defines an exact CD protocol for the evolutionary
system.
Given an arbitrary continuous time sequence of IE distributions ρ
(
x;λ(t)
)
, such a perturbation always exists. In
fact, from a formal mathematical standpoint56, any perturbation of the following form is a solution (note that for
clarity we do not use Einstein summation in this case):
δs˜
(
x;λ(t),
.
λ(t)) = g−1(x)
[
1
ρ
(
x;λ(t)
) (−M−1∑
i=1
xˆiwi
∫ xi
0
dx′i ∂tρ
(
x1, . . . ,x
′
i, . . . ,xM−1;λ(t)
)
+f
(
x;λ(t),
.
λ(t)
))]
.
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(14)
Here g−1(x) is the inverse of the matrix g(x), xˆi is the unit vector along the ith axis, and the integral in the ith
term of the sum is carried out only over the ith genotype fraction, keeping all other components xj , j 6= i, fixed.
There are two quantities in Eq. (14) that make the solution potentially non-unique: the weights wi can be any real
numbers, so long as
∑M−1
i=1 wi = 1; and f
(
x;λ(t),
.
λ(t)
)
is an (M −1)-dimensional vector function which has zero
divergence, ∂ifi = 0. However we an have additional constraints on this function f : it has to be compatible with the
vanishing of the current orthogonal to boundary, Jini = 0. For M = 2, where necessarily w1 = 1, these constraints
mean that only f = 0 is allowed, and we get a unique exact CD solution. For M > 2, the partial differential equation
∂ifi = 0 and the boundary condition do not specify f uniquely, and hence we get many possible allowable CD
solutions all of which satisfy Eq. (13). This in turn means that we can always find CD Fokker-Planck operators
L˜(λ(t), .λ(t)) that satisfy main text Eq. (3).
However the formal existence of such perturbations δs˜ is not the end of the story, because many of the solutions
described by Eq. (14) may not be physically realizable. In order to get at a more practical (though approximate) CD
solution, we proceed as follows. As discussed Sec. 4.2, in the regime of interest it is easier to work with moments of
the IE distribution, so it is useful to convert Eq. (13) into a relation involving the IE first moment xi(λ). Multiply
both sides of Eq. (13) by xk, and notice that xk∂iJi = ∂i (xkJi)− δikJi, where δik is the Kronecker delta function.
Integrating over the entire simplex gives
∫
∆
dxxk∂tρ(x;λ(t)) =−
∫
∆
dx∂i (xkJi) +
∫
∆
dxJk. (15)
By Gauss’s theorem,
∫
∆ dx∂i (xkJi) =
∫
∂∆ dσxkJini, where the integral involves area elements dσ of the simplex
boundary ∂∆, and ni are the components of the normal vector to this boundary. By conservation of probability, the
component of J normal to ∂∆ vanishes, i.e. Jini = 0, so the first term in Eq. (15) is zero. Plugging the definition
of Jk into the second term, we get
∫
∆
dxxk∂tρ(x;λ(t)) =
∫
∆
dxρ(x;λ(t))gkj(x)δs˜j(x;λ(t),
.
λ(t)), (16)
or equivalently
∂tx(λ(t)) =
〈
g(x)δs˜
(
x;λ(t),
.
λ(t)
)〉
, (17)
where the brackets 〈 〉 denote an average over the simplex with respect to ρ(x;λ(t)).
So far both Eq. (13) and (17) are exact relations satisfied by the CD perturbation δs˜. However we can
simplify the results in the large population, frequent mutation regime, where ρ(x;λ(t)) has the approximate normal
form of Eq. (10). As argued in the SI, in this case the leading contribution to δs˜ is frequency-independent,
δs˜(x;λ(t),
.
λ(t)) ≈ δs˜(λ(t), .λ(t)), with corrections that vanish in the large N limit. The leading contribution
δs˜(λ(t),
.
λ(t)) satisfies a version of Eq. (17) with x on the right-hand side replaced by the IE mean x(λ(t)),
∂tx(λ(t)) = g
(
x(λ(t))
)
δs˜
(
λ(t),
.
λ(t)
)
. (18)
This equation can be directly solved for δs˜(λ(t),
.
λ(t)) in terms of x(λ(t)), yielding the approximate CD solution of
main text Eq. (4). Thus knowing the IE first moment x(λ(t)) over the duration of the protocol (via the numerical
procedure described in the SI) allows us to estimate a CD driving prescription.
4.4 CD driving for the two genotype example
For the M = 2 system, the exact IE distribution is given by Eqs. (8)-(9). In the large population, frequent mutation
limit we can estimate the mean frequency x1(λ(t)) corresponding to this distribution as:
x1(λ(t))≈
−m12−m21 +s1(λ(t)) +
√(
m12 +m21−s1(λ(t))
)2 + 4m12s1(λ(t))
2s1(λ(t))
. (19)
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This allows the CD prescription in Eq. (4) to be evaluated analytically, yielding
s˜1
(
λ(t),
.
λ(t)
)
= s1
(
λ(t)
)
+
∂ts1
(
λ(t)
)√(
m12 +m21−s1
(
λ(t)
))2 + 4m12s1(λ(t)) . (20)
For the results in Fig. 2, we assume the following ramp for the selection coefficient: s1
(
λ(t)
)
=σ/(1+ae−kt)−σ/(1+a),
with σ = 0.02, a= 817, k = 0.06. The other model parameters are set to: N = 104, m12 =m21 = 2.5×10−3.
4.5 Agent based model
4.5.1 Model description
For the agent based model (ABM) simulations, we track a population of single-celled organisms that undergo birth
(through binary division), death, and mutations. There are M genotypes, and the fitness of genotype i <M relative
to the Mth one (the wildtype) is 1+si(λ(τ)), which depends on the drug dosage λ(τ) at the current simulation time
step τ . (The mapping between simulation time steps τ and Wright-Fisher generations t will be discussed below.) At
each simulation time step, every cell in the population undergoes the following process: i) with probability d it dies;
ii) if it survives, the cell divides with a genotype-dependent probability
bi(τ) =
{
min
(
b0(1 +si(λ(τ))
(
1− Ncell(τ)K
)
,1
)
Ncell(τ)≤K
0 Ncell(τ)>K,
(21)
where i is the cell’s genotype, b0 is a baseline birth rate, Ncell(τ) is the current number of cells in the population,
and K is the carrying capacity. Upon division, the daughter cell mutates to another genotype j with probability
mˆji, j 6= i.
4.5.2 In silico implementation
The ABM was implemented for the M = 2 and M = 16 examples described in the main text using code written in
the C++ programming language. Code, configuration files, and analysis scripts for these models can be found on
https://github.com/Peyara/Evolution-Counterdiabatic-Driving. The code directly implements the model
of the previous section, and is summarized in the flowchart of Fig. 4. The M = 2 selection coefficient s1(λ(t)) and
other model parameters are as described in the main text.
For M = 16, the simulations were run for 4.5×104 time steps with a death rate d= 0.05, a baseline birth rate
b0 = 2, and a carrying capacity K = 5× 106. The mutation probability mˆji, j 6= i is zero unless the Hamming
distance between the binary string representation of i and j is 1. This gives the “tesseract” connectivity seen in
Fig. 3A,D. Where nonzero, the probability mˆji = 2.5×10−4, giving a total mutation probability
∑
j 6=i mˆji = 10−3
for all offspring. To give the population time to reach an initial equilibrium, the drug concentration λ(τ) is initially
small, increases substantially around time step τ ∼ 104, and then plateaus at later times. The dosage follows the
equation,
λ(τ) = a
1 + exp
(− b(τ − c)) , (22)
with parameters: a= 1.5×10−4 M, b= 2×10−3, c= 10,110. The selection coefficients si(λ(τ)) were varied with
concentration λ(τ) in accordance with the experimentally measured dose-fitness curves of 16 genotypes for the
anti-malarial drug pyrimethamine2,3. To calculate distributions of genotype frequencies, every simulation is repeated
1000 times.
4.5.3 Mapping the ABM simulations to a Fokker-Planck equation
In order to implement the CD driving protocol, derived for Wright-Fisher Fokker-Planck dynamics, in the context of
the ABM, we need a mapping between the ABM parameters and the corresponding Fokker-Planck parameters. As
shown in the SI, this can be done by describing the ABM simulation population updating at each time step as an
effective Langevin equation, and then using the connection between the Langevin and Fokker-Planck descriptions55,57.
The resulting approximate correspondence is summarized as follows: i) a duration of τ ABM simulation time steps
maps to t≈ τd Wright-Fisher generations, where d is the ABM death rate. ii) The Fokker-Planck mutation matrix
entries miν , i 6= ν, are given by miν ≈ mˆiν(1+sν), where mˆiν are the ABM mutation probabilities. iii) The effective
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Figure 4. Flow chart describing the code executed at each time step by ABMs in this paper. M refers to the total
number of genotypes in the model, d to the death rate, and bgenotype to the birth rate of the current genotype.
Random numbers in the chart are drawn uniformly from the range 0 to 1.
population N in the Fokker-Planck model is given by N ≈ 12K(1−db−10 (1−d)−1), where K is the ABM carrying
capacity and b0 the baseline birth rate. The accuracy of this mapping is illustrated in Fig. 2A,C, where the
distributions from ABM simulations for M = 2 (red circles) are compared against numerical Fokker-Planck solutions
with parameters calculated using the mapping (red curves).
4.5.4 Numerical estimation of the KL divergence and reduction in lag time
To quantify the effectiveness of the CD driving, we use the KL divergence between the actual distribution, p(x, t) and
the IE one, ρ(x;λ(t)), defined as DKL(ρ||p) =
∫
dxρ(x;λ(t)) log2
(
ρ(x;λ(t))/p(x, t)
)
. For M = 2, the Fokker-Planck
equation can be solved numerically for p(x1, t), while ρ(x1;λ(t)) is known analytically (Eqs. (8)-(9)). Hence the
one-dimensional integral for DKL(ρ||p) can be numerically evaluated. For M = 16 the situation becomes more
complicated. There is no analytical solution for ρ(x;λ(t)), but we do have a good approximation in terms of the
multivariate normal distribution of Eq. (10), expressed in terms of the mean vector x(λ(t)) and covariance matrix
Σ(λ(t)) that are calculated using the moment approach described in the SI. The ABM simulation results are also
normally distributed in this parameter regime, and hence there is a corresponding simulation mean xsim(t) and
covariance Σsim(t) that can be calculated at each time t. These are calculated from the ensemble of 1000 simulations
that are run for each parameter set. The integral for the KL divergence DKL(ρ||p) between the simulation and IE
multivariate normal distributions can then be evaluated directly, yielding
DKL(ρ||p) = 12ln2
[
ln detΣsim(t)detΣ(λ(t)) −M + 1 + tr
(
Σ−1sim(t)Σ(λ(t))
)
+ (xsim(t)−x(λ(t)))T Σ−1sim(t)(xsim(t)−x(λ(t)))
]
(23)
Since Σsim(t) will have some degree of sampling errors due to the finite size of the simulation ensemble, it can in
some cases be badly conditioned. In these scenarios the Moore-Penrose pseudo-inverse is used to estimate Σ−1sim(t).
We can use the curves of DKL(ρ||p) as a function of time, for example those of Fig. 3F, to estimate how much
lag time ∆t is being eliminated using a given approximate CD protocol, relative to the original one. This lag time
savings ∆t= torigeq − tCDeq , where torigeq and tCDeq are respectively the times at which probability distributions in the
original and CD protocols reach their final IE target values. In terms of DKL(ρ||p), there is minimum value DeqKL
attained at long times when p(x, t) has converged with ρ(x;λ(t)). Note this value is not precisely zero because of
numerical noise associated with the estimation of the distribution p(x, t) from a finite number of simulations. At
long times when DKL(ρ||p) approaches DeqKL, the final approach can be fit well by the following exponential decay
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function,
DKL(ρ||p)≈
{
DeqKLe
−(teq−t)/τ t≤ teq
DeqKL t > teq
. (24)
Since we know DeqKL from the long-time behavior of the KL divergence curves, we then can estimate τ and teq by
fitting Eq. (24) to the final decay portion of each DKL(ρ||p) curve (the time range where DKL(ρ||p) is within two
orders of magnitude of DeqKL). After finding teq for the original and CD protocols, the difference gives us the ∆t
values quoted in the main text and SI.
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A Fokker-Planck analogue of quantum adiabatic theorem
The Fokker-Planck dynamics of our model obeys a classical, stochastic analogue of the quantum adiabatic theorem33,58.
As described in the main text, this means that if the system starts at t= t0 in the equilibrium distribution ρ(x;λ(0))
corresponding to control parameter λ(0), it will remain in the corresponding instantaneous equilibrium (IE)
distribution ρ(x;λ(t)) at all t > t0 if λ(t) is varied infinitesimally slowly. Note that for the quantum case, if a system
starts in any eigenstate of the Hamiltonian, it will remain in that eigenstate if the Hamiltonian is varied adiabatically,
assuming the eigenvalues never become degenerate. The classical version that we demonstrate here only applies to
one eigenstate, the IE distribution, which corresponds to the quantum ground state.
A.1 Fokker-Planck eigenfunction expansion, adjoint operator
Before considering adiabatic driving, we start with some preliminaries for a Fokker-Planck (FP) system with a
time-independent control parameter λ(t) = λ. The FP operator for a given λ is defined in Eq. (5) of the Methods,
L(λ)p(x, t)≡−∂i (vi(x;λ)p(x, t))+∂i∂j(Dij(x)p(x, t)). (S1)
Throughout the Supplementary Information (SI) we will use the same Einstein summation notation that we described
in the Methods, with repeated Roman indices summed from 1 to M −1 and repeated Greek indices summed from 1
to M . The two exceptions for clarity will be: i) the eigenfunction indices n and m used in this section, where the
summation convention will not apply and explicit sums will be always be indicated; ii) the final section describing
the mapping between the agent-based model and the Fokker-Planck equation, where it will be more convenient to
write out all sums explicitly.
The operator L(λ) has an associated set of eigenfunctions ψn(x;λ) and eigenvalues −κn(λ), satisfying32
L(λ)ψn(x;λ) =−κn(λ)ψn(x;λ) (S2)
for n= 0,1,2, . . .. We assume an equilibrium distribution exists for every value of the control parameter λ, in which
case we know one eigenvalue is zero. By convention we choose this to be n= 0, so κ0(λ) = 0, and the corresponding
eigenfunction ψ0(x;λ) ≡ ρ(x;λ). Eigenvalues for n > 0 can be in general complex, but have positive real parts,
Re(κn(λ))> 0, which guarantees that the system eventually equilibrates, as discussed below32,59.
The Fokker-Planck equation for constant λ,
∂tp(x, t) = L(λ)p(x, t) (S3)
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has a solution that can be expressed as a linear combination of the eigenfunctions,
p(x, t) =
∞∑
n=0
cnψn(x;λ)e−κn(λ)t, (S4)
for some constants cn where c0 = 1. The fact that Re(κn(λ))> 0 for n > 0 ensures eventual equilibration: p(x, t)→
ψ0(x;λ) = ρ(x;λ) as t→∞.
It is convenient to introduce the adjoint L†(λ) of the FP operator32,59,
L†(λ)p(x, t)≡ vi(x;λ)∂ip(x, t) +Dij(x)∂i∂jp(x, t), (S5)
with corresponding eigenfunctions ξn(x;λ),
L†(λ)ξn(x;λ) =−κ∗n(λ)ξn(x;λ). (S6)
where the asterisk denotes complex conjugation. Let us define the scalar product of two functions f(x;λ) and h(x;λ)
through
〈f,h〉λ ≡
∫
∆
dxf(x;λ)h∗(x;λ) (S7)
where the integral is over the M −1 dimensional simplex ∆ defined in the Methods, and the λ subscript denotes the
dependence on λ. Then L†(λ) has the conventional property of an adjoint:
〈Lf,h〉λ = 〈f,L†h〉λ. (S8)
A consequence of this property, using f = ψn and h = ξm, is that the eigenfunctions can be chosen to ensure
biorthonormality of the form
〈ψn, ξm〉λ = δnm, (S9)
where δnm is the Kronecker delta. By inspection of Eq. (S5) one can see that the n= 0 adjoint eigenfunction, with
eigenvalue κ∗0(λ) = 0, is ξ0(x;λ) = 1. The biorthonormality relation in this case,
1 = 〈ψ0, ξ0〉λ =
∫
∆
dxρ(x;λ) (S10)
corresponds to the normalization of the equilibrium distribution ρ(x;λ). We also know that for n > 0,
0 = 〈ψn, ξ0〉λ =
∫
∆
dxψn(x;λ). (S11)
This property ensures that p(x, t) from Eq. (S4), with c0 = 1, is also properly normalized,
∫
∆ dxp(x, t) = 1.
A.2 Fokker-Planck adiabatic driving
We now allow the control parameter λ(t) to vary with time. At any given time t, the definitions of the previous
section generalize to give instantaneous operators L(λ(t)), L†(λ(t)), and corresponding instantaneous eigenfunc-
tions/eigenvalues ψn(x;λ(t)), ξn(x;λ(t)) and κn(λ(t)). The dynamics of the system are now described by the FP
equation
∂tp(x, t) = L(λ(t))p(x, t). (S12)
Working by analogy with the standard proof of the quantum adiabatic theorem58, let us posit a solution to this
equation of the form
p(x, t) =
∞∑
n=0
cn(t)ψn(x;λ(t))e−Θn(t), (S13)
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where cn(t) are some functions to be determined and Θn(t)≡
∫ t
t0
dt′κn(λ(t′)). Plugging Eq. (S13) into Eq. (S12),
and using the fact that L(λ(t))ψn(x;λ(t)) =−κn(λ(t))ψn(x;λ(t)), we see the p(x, t) form satisfies the FP equation
assuming the following relation is true:
∞∑
n=0
.
cn(t)ψn(x;λ(t))e−Θn(t) =−
∞∑
n=0
cn(t)
.
λ(t)∂λψn(x;λ(t))e−Θn(t), (S14)
where
.
f(t) ≡ df/dt for a function f(t). Taking the scalar product of both sides with respect to ξm(x;λ(t)), and
using the biorthonormality relations we find a set of coupled differential equations for m = 0,1,2, . . . that can in
principle be used to solve for the functions cn(t) if we knew the eigenfunctions/eigenvalues:
.
cm(t) =−
∞∑
n=0
cn(t)
.
λ(t)〈∂λψn, ξm〉λ(t)e−(Θn(t)−Θm(t)). (S15)
For m = 0 the relations in Eqs. (S10)-(S11) allow us to simplify the above to .c0(t) = 0, which means c0(t) is
time-independent (and has to be equal to 1 to ensure normalization). Thus we can write Eq. (S13) as
p(x, t) = ρ(x;λ(t)) +
∞∑
n=1
cn(t)ψn(x;λ(t))e−Θn(t). (S16)
Let us imagine that we start at t0 in equilibrium, so cn(0) = 0 for n > 0. For a general control protocol λ(t),
Eq. (S15) implies that cn(t), n > 0, would not necessarily stay zero at later times t > t0. Hence p(x, t) in Eq. (S16)
would gain contributions from higher eigenfunctions in the second term, and no longer remain in the IE distribution.
This is the classical analogue of the observation that for a general time-dependent Hamiltonian driven at a finite
rate, a quantum system that started in a ground state will evolve into a superposition of instantaneous ground and
excited states.
However if the driving was infinitesimally slow,
.
λ(t)→ 0, then the right-hand side of Eq. (S15) becomes negligible,
and hence cn(t)≈ 0 for n > 0. Thus for adiabatically slow driving, p(x,t)≈ ρ(x;λ(t)) at all times t > t0. The system
remains in the IE distribution, just like the corresponding quantum system remains in the instantaneous ground
state.
B Derivation of vi and Dij for Fokker-Planck Wright-Fisher model with mutation and selec-
tion
To derive the expressions for vi and Dij in Eqs. (6)-(7) of the Methods, we start with haploid WF evolutionary
dynamics defined as follows: each time step corresponds to a generation, and every new generation is created by each
child randomly “choosing” a parent in the previous generation and copying the parental genotype. Let N be the
total population, assumed fixed between generations (i.e. at carrying capacity). Let φi(x;λ(t)) be the probability of
choosing a parent of genotype i, which may depend on the control parameter λ(t) through its influence on selection
coefficients. In the absence of mutation and selection, φi(x;λ(t)) = xi, the fraction of that genotype in the parental
generation. However we will keep φi general, in order to incorporate mutation / selection effects later on. The
probability of the new generation having a set of genotype populations n ≡ (n1,n2, . . . ,nM−1), where ni is the
number of type i individuals, is given by the multinomial distribution,
P(n;x,λ(t)) = N !
n1!n2! · · ·nM−1!nM !φ
n1
1 (x;λ(t))φ
n2
2 (x;λ(t)) · · ·φ
nM−1
M−1 (x;λ(t))φ
nM
M (x;λ(t)) (S17)
where nM =N −
∑M−1
j=1 nj is the number of type M individuals. Note that Eq. (S17) is defined for all allowable
configurations of types, or in other words for any n where N −∑M−1j=1 nj ≥ 0. If we denote ∑n as a sum over
these allowable configurations, then
∑
nP(n;x;λ(t)) = 1. The genotype fraction x′i in the new generation is just
x′i = ni/N , and hence the mean difference vi(x;λ(t)) in genotype fractions per generation can be expressed as
vi(x;λ(t)) = 〈δxi〉= 〈x′i−xi〉=
∑
n
(ni
N
−xi
)
P(n;x,λ(t)) = φi(x;λ(t))−xi. (S18)
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Similarly Dij(x;λ(t)) can be calculated through the covariance as:
2Dij(x;λ(t)) = 〈δxiδxj〉−〈δxi〉〈δxj〉
=
〈(ni
N
−xi
)(nj
N
−xj
)〉
− (φi(x;λ(t))−xi)(φj(x;λ(t))−xj)
= gij(φ(x;λ(t)))
N
,
(S19)
where gij(φ(x;λ(t))) is given by Methods Eq. (7) with φ(x;λ(t)) = (φ1(x;λ(t)), . . . ,φM−1(x;λ(t))) replacing x. In
order to derive Eqs. (S18)-(S19), we have used the mean and covariance properties of the multinomial distribution
of Eq. (S17):
〈ni〉=Nφi(x;λ(t)),
〈ninj〉−〈ni〉〈nj〉=
{
Nφi(x;λ(t))(1−φi(x;λ(t))) j = i
−Nφi(x;λ(t))φj(x;λ(t)) j 6= i
.
(S20)
To complete the derivation, we need an expression for φi(x;λ(t)) when mutation and selection are included in the
model. Consider first the probability φ0i (x) of picking a parent of type i, assuming only mutation was allowed, but no
selection. Accounting for the gain and loss of possible type i parents through mutation, we have φ0i (x) = xi+miµxµ,
for 1≤ i≤M −1. We can express the probability to choose a parent of type M as φ0M (x) = 1−
∑M−1
j=1 φ
0
j (x) by
normalization. To include selection and obtain the final expressions for φi(x;λ(t)), we note that we can write
φi(x;λ(t))
φM (x;λ(t))
= (1 +si(λ(t)))
φ0i (x)
φ0M (x)
[no summation over i], (S21)
Eq. (S21), for i= 1, . . . ,M−1, states that the ratio of φi(x;λ(t)), the chance of picking a type i parent, to φM (x;λ(t)),
the chance of picking a wild type parent, is modified by a factor 1 + si(t) due to selection, compared to the case
without selection. In other words, if si(t) is positive because type i has a greater fitness than the wild type, the
chance of getting a type of i parent relative to a wild type parent increases by 1 +si(t). Recalling the definition of
φM (x;λ(t)) in terms of φ(x;λ(t))’s components, we can solve the systems of equations in Eq. (S21) to find
φi(x;λ(t)) =
(1 +si(λ(t)))φ0i (x)
1 +sj(λ(t))φ0j (x)
[no summation over i]. (S22)
Let us substitute in the expression for φ0i (x), and make the typical assumption that |si(λ(t))|, |mij |  1. After
Taylor expanding to first order in these quantities, Eq. (S22) becomes
φi(x;λ(t))≈ xi+miµxµ+gij(x)sj(λ(t)). (S23)
Plugging this into Eq. (S18) gives the expression in Methods Eq. (6) for vi. Similarly, if we plug Eq. (S23) into
Eq. (S19), and keep only the leading order contribution, we get Dij(x)≈ gij(x)/(2N), which is the expression in
Methods Eq. (6) for Dij .
C Estimating the mean and covariance of the instantaneous equilibrium distribution
As discussed in the Methods, for general M we do not have an analytical expression for IE distribution. However
in the large population, frequent mutation regime we can use the multivariate normal approximation of Methods
Eq. (10). This requires us to be able to calculate the mean genotype frequencies xi(λ) and covariance matrix Σ(λ)
associated with the IE distribution ρ(x;λ) at a given value of the control parameter λ. In this section we outline
how to do this calculation. The first step is deriving a set of coupled equations for the first and second moments of
the IE distribution (part of a larger hierarchy of moment equations). The second step will be to approximately solve
these equations using a moment closure technique. We consider each step in turn.
C.1 Deriving equations for the first and second moments of the IE distribution
In order to characterize the moments of the IE distribution ρ(x;λ), let us consider an auxiliary problem: imagine a
system described by a genotype frequency probability p˜(x, τ) evolving under a Fokker-Planck equation with constant
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λ:
∂τ p˜(x, τ) = L(λ)p˜(x, τ)
=−∂i
[
vi(x;λ)p˜(x, τ) +∂j
(
Dij(x)p˜(x, τ)
)]
≡−∂iJi(x, τ),
(S24)
where for later convenience we have introduced the probability current Ji(x, τ). We know that in the limit τ →∞
the system equilibrates, p˜(x, τ)→ ρ(x;λ). We use the auxiliary time τ here for clarity, since it is distinct from the
actual time t in the original system. Let us define the first and second moments of the genotype frequencies with
respect to p˜(x, τ):
〈xi〉τ ≡
∫
∆
dxxip˜(x, τ), 〈xixj〉τ ≡
∫
∆
dxxixj p˜(x, τ), (S25)
where the τ subscript denotes the dependence of the moments on τ . Since p˜(x, τ)→ ρ(x;λ) as τ →∞, the IE
distribution quantities we are interested in are just the following limiting values:
xi(λ) = lim
τ→∞〈xi〉τ , Σij(λ) = limτ→∞(〈xixj〉τ −〈xi〉τ 〈xj〉τ ) . (S26)
We will derive the following exact moment relationships:
0 = miµxµ(λ) +
[
xi(λ)δik−Σik(λ)−xi(λ)xk(λ)
]
sk(λ), (S27)
0 = miµΣjµ(λ) +mjµΣiµ(λ) + Σij(λ)
(
si(λ) +sj(λ)
)
(S28)
−[2Tijk(λ)−xj(λ)Σik(λ)−xi(λ)Σjk(λ)−2xi(λ)xj(λ)xk(λ)]sk(λ)
+ 1
N
[
xi(λ)δij−Σij(λ)−xi(λ)xj(λ)
]
,
where i, j = 1, . . . ,M −1 (the indices i, j are not summed over). Here Tijk(λ)≡ limτ→∞〈xixjxk〉τ is a third moment
of the IE distribution. The derivation of these equations is shown below. For readers not interested in the details,
they can skip ahead to Sec. C.2.
To find Eq. (S27), let us start with the first moment 〈xi〉τ from Eq. (S25), take the derivative with respect to τ ,
and plug in the Fokker-Planck equation from Eq. (S24):
d
dτ
〈xi〉τ =
∫
∆
dxxi∂τ p˜(x, τ) =−
∫
∆
dxxi∂jJj(x, τ), (S29)
Notice that xi∂jJj = ∂j(xiJj)− δijJj . By Gauss’s theorem, the integral over the first term is
∫
∆ dx∂j(xiJj) =∫
∂∆ dσxiJjnj . The latter integral is expressed in terms of area elements dσ of the simplex boundary ∂∆, and nj
is the jth component of the normal vector to this boundary. Since probability is conserved within the simplex,
Jjnj = 0, and hence the integral vanishes. Thus only the integral over the second term contributes, and Eq. (S29)
can be rewritten:
d
dτ
〈xi〉τ =
∫
dxJi(x, τ) =
∫
dx
[
vi(x;λ)p˜(x, τ)−∂j (Dij(x)p˜(x, τ))
]
. (S30)
Focusing on the second term of the integrand in Eq. (S30), we can rewrite this term using Gauss’s law as:
−
∫
∆
dx∂j (Dij(x)p˜(x, τ)) =−
∫
∂∆
dσ p˜(x, τ)Dij(x)nj =− 12N
∫
∂∆
dσ p˜(x, τ)gij(x)nj . (S31)
The term gij(x)nj = 0 for x ∈ ∂∆, which makes the integral vanish. We prove this in the following lemma.
Lemma: For gij(x) as defined in Methods Eq. (7) and for any normal vector n to the simplex boundary ∂∆,
gij(x)nj = 0 for all x ∈ ∂V . .
Proof: A simplex is defined by ∆ = {x |xi ≥ 0, xiei 6 1}, where e is an M − 1 dimensional vector with all
components equal to 1. There are two classes of hypersurfaces on the simplex boundary (where xiei = 1) to
consider:
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Case 1: One type of hypersurface on the simplex boundary is Sk, defined by the conditions xk = 0 and xjej = 1.
There are M −1 such hypersurfaces, one for each k = 1, . . . ,M −1. The components of the normal vector nk
to Sk are given by nkj =−δkj (the minus sign ensures nk faces away from the simplex volume). Then, for all
x ∈ Sk, gij(x)nkj =−gij(x)δkj =−gik(x), and we know from the definition of g that gik(x)∝ xk = 0. The
last result follows because xk = 0 for x ∈ Sk.
Case 2: The only other type of hypersurface on the simplex boundary is S′, defined by the conditions
xi > 0 for all i, and xiei = 1. We find the normal to this surface as follows. Define F (x) = xiei−1. Then
n=∇F = e. For all x ∈ S′, we have gij(x)nj = gij(x)ej = xi(1−xjej). Since xjej = 1 for all x ∈ S′, we see
that gij(x)nj = 0.
Using the lemma, and the definition of vi(x;λ) from Methods Eq. (6), we can rewrite Eq. (S30) as:
d
dτ
〈xi〉τ =
∫
dxvi(x;λ)p˜(x, τ) = 〈vi(x;λ)〉τ
=miµ〈xµ〉τ + 〈gij(x)〉τsj(λ).
(S32)
Taking the τ →∞ limit on sides of the equation, we note that the left-hand side vanishes because 〈xi〉τ → xi(λ),
a constant independent of τ . On the right-hand side we can subsitute in Eq. (S25) and use the definition of g in
Methods Eq. (7). The end result is Eq. (S27). This is the first moment equation we will be interested in.
To derive Eq. (S28), we start analogously to Eq. (S29), but now with the second moment:
d
dτ
〈xixj〉τ =
∫
∆
dxxixj∂τ p˜(x, τ) =−
∫
∆
dxxixj∂kJk(x, τ). (S33)
Notice, by the product rule, that xixj∂kJk = ∂k(xixjJk)−Jk∂k(xixj) = ∂k(xixjJk)−Jixj−Jjxi. By Gauss’ law,
we have
∫
∆ dx∂k(xixjJk) =
∫
∂∆ dσxixjJknk. Since probability is conserved, Jknk = 0, and we can thus rewrite
Eq. (S33) as:
d
dτ
〈xixj〉τ =
∫
dx(Jixj +Jjxi)
=
∫
dx
[(
vi(x;λ)p˜(x, τ)−∂k
(
Dik(x)p˜(x, τ)
))
xj +
(
vj(x;λ)p˜(x, τ)−∂k
(
Djk(x)p˜(x;τ)
))
xi
]
.
(S34)
Note that ∂k(Dikp˜)xj = ∂k(Dikp˜xj)−Dikp˜∂kxj = ∂k(Dikp˜xj)−Dikp˜δjk = ∂k(Dikp˜xj)−Dij p˜. By Gauss’s theorem,
−
∫
∆
dx∂k (Dik(x)p˜(x, τ)xj) =−
∫
∂∆
dσ p˜(x, τ)xjDik(x)nk =− 12N
∫
∂∆
dσ p˜(x, τ)xjgik(x)nk. (S35)
By the lemma, gik(x)nk = 0 for x ∈ ∂∆, so the integral vanishes. Using this and the fact that Dij =Dji, Eq. (S34)
becomes
d
dτ
〈xixj〉τ =
∫
∆
dx
[
xjvi(x;λ)p˜(x, τ) +xivj(x;λ)p˜(x, τ) + 2Dij(x)p˜(x, τ)
]
= 〈xjvi(x;λ)〉τ + 〈xivj(x;λ)〉τ + 2〈Dij(x)〉τ .
(S36)
In the τ →∞ limit this equation can be written in the form of Eq. (S28).
C.2 Approximate solution of moment equations
Eqs. (S27) and (S28) constitute the first two of a hierarchy of coupled moment equations, with each set of equations
involving moments of one higher order (i.e. Eq. (S27) involves Σij , Eq. (S28) involves Tijk). In the limit N →∞
Eq. (S28) for the second moments can be trivially satisfied, because the IE distribution becomes a delta function
with zero spread. In this case Σij(λ) = 0, Tijk(λ) = xi(λ)xj(λ)xk(λ) is a solution to Eq. (S28). For large but finite N
(assuming µN  1 is still satisfied, where µ is the order of magnitude of the nonzero mutation rates) the distribution
becomes spread out by a small amount, and we will approximate it by a multivariate Gaussian. As a result we
assume third and higher order cumulants are negligible, which will allow us to approximately solve Eqs. (S27) and
(S28) for xi(λ) and Σij(λ). This approach, known as moment closure, effectively truncates the moment hierarchy
after the second order. It is justified by the fact that while Σij(λ) scales like N−1, the third cumulant scales like
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N−2, etc., which allows the higher order cumulants to be neglected for large N . Letting the third cumulant be zero
means the third moment can be approximated as follows:
Tijk(λ)≈ xi(λ)Σjk(λ) +xj(λ)Σik(λ) +xk(λ)Σij(λ) +xi(λ)xk(λ)xk(λ). (S37)
Plugging this into Eq. (S28) gives:
0≈miµΣjµ(λ) +mjµΣiµ(λ) + Σij(λ)
(
si(λ) +sj(λ)
)
− [2xk(λ)Σij(λ) +xi(λ)Σjk(λ) +xj(λ)Σik(λ)]sk(λ)
+ 1
N
[
xi(λ)δij−Σij(λ)−xi(λ)xj(λ)
]
.
(S38)
For Eq. (S27), since the term Σik(λ)∼O(N−1) becomes negligible relative to the other terms for large N , we can
approximate the equation as
0≈miµxµ(λ) +
[
xi(λ)δik−xi(λ)xk(λ)
]
sk(λ). (S39)
The following procedure can then be used to solve Eqs. (S38)-(S39): i) numerically solve the nonlinear set of
equations in Eq. (S39) for xi(λ), i= 1, . . . ,M −1. ii) Plug this solution into Eq. (S38), and then numerically solve
the resulting set of linear equations for Σij(λ), i, j = 1, . . . ,M −1. Because the Σ indices in Eq. (S38) run up to M ,
we use the following identities to express those elements in terms of lower indices: ΣMM = Σk`eke`, ΣiM =−Σikek.
Both of these identities follow from the fact that xM = 1−xkek.
In principle we can iterate this procedure to progressively add small corrections to the solution, converging
to self-consistency between Eq. (S27) and Eq. (S38): plug the Σij(λ) values obtained from the first iteration into
Eq. (S27), solve for the updated xi(λ), plug these into Eq. (S38), and so on. However for all the cases we examined
in the main text the corrections resulting from multiple iterations are negligible, so we use one iteration only.
D Approximating the counterdiabatic driving protocol in the large population, frequent mu-
tation regime
As derived in Methods Sec. 4, the selection coefficient perturbation δs˜
(
x;λ(t),
.
λ(t)) = s˜
(
x;λ(t),
.
λ(t))−s(λ(t)) needed
to implement the CD protocol satisfies Methods Eq. (13):
∂tρ
(
x;λ(t)
)
=−∂i
(
ρ
(
x;λ(t)
)
gij(x)δs˜j
(
x;λ(t),
.
λ(t)
))
, (S40)
which in turn implies the relation in Methods Eq. (17),
∂tx(λ(t)) =
〈
g(x)δs˜
(
x;λ(t),
.
λ(t)
)〉
. (S41)
Here the brackets 〈 〉 denote an average over the simplex with respect to the IE distribution ρ(x;λ(t)). Let us
define a function F (x)≡ g(x)δs˜(x;λ(t), .λ(t)). For simplicity of notation we do not explicitly show the λ(t), .λ(t)
dependence in F (x). We can then Taylor expand the right-hand side of Eq. (S41) around x(λ(t)) up to second
order. In component form, this looks like
∂txi(λ(t)) = 〈Fi(x)〉
= Fi
(
x(λ(t))
)
+∂jFi
(
x(λ(t))
)〈xj−xj(λ(t))〉+ 12∂j∂kFi(x(λ(t)))〈(xj−xj(λ(t)))(xk−xk(λ(t)))〉+ · · ·
= Fi
(
x(λ(t))
)
+ 12∂j∂kFi
(
x(λ(t))
)
Σjk(λ(t)) + · · ·
(S42)
In the last line we have used the definition of the IE covariance matrix Σjk(λ(t)), and the fact that 〈xj−xj(λ(t))〉= 0
since xj(λ(t)) is the mean of the IE distribution. From the discussion in the previous section we know that Σjk(λ(t))
scales like N−1 when N is large (and µN  1). This means that the Σ term in Eq. (S42) becomes small compared
to the leading term for large N . Keeping only the leading term, and substituting in the definition of F (x), we find
the approximate relation
∂tx(λ(t))≈ g
(
x(λ(t))
)
δs˜
(
λ(t),
.
λ(t)
)
, (S43)
where δs˜
(
λ(t),
.
λ(t)
)≡ δs˜(x(λ(t));λ(t), .λ(t)). This is what is shown in Methods Eq. (18).
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Figure S1. (A) Five examples of time-varying total populations N(t) =N0(1 + ζsi(λ(t)) for the two genotype
system described in Methods Sec. 4.4. Here N0 = 104 and ζ =−40, −20, 0, 200, and 450. (B) For each case in
panel A, the Kullback-Leibler divergence between the IE and actual genotype frequency distributions while driving
the system according to the original protocol (dashed curves) or the approximate CD protocol (solid curves). Colors
are matched to the ζ values indicated in panel A. The KL divergences are calculated using numerical solutions to
the associated Fokker-Planck equations.
E Counterdiabatic driving under time-varying total populations
The derivation of the CD protocol discussed in Methods Sec. 4 and the previous section of the SI remains valid even
when the total population N(t) varies in time as a result of the control protocol, i.e. the carrying capacity of the
system changes along with the control parameters. In this case we can effectively absorb N(t) into the set of control
parameters λ(t) during the derivation, and we end up with the same approximate CD protocol defined through
Eq. (S43), and whose explicit solution is shown in main text Eq. (4). This assumes the conditions for the validity of
the approximation hold at all times of interest, N(t) 1 and µN(t) 1. It is interesting to note that main text
Eq. (4) depends only on the selection coefficients under the protocol si(λ(t)) and the corresponding instantaneous
equilibrium mean genotype frequencies xi(λ(t)). As can be seen from Eq. (S39), to leading order for large N(t) the
means xi(λ(t)) are independent of N(t). If the selection coefficients are also independent of N(t) then the entire CD
driving protocol becomes (at least to leading order) independent of N(t). Thus the same CD protocol should work
for a variety of N(t) behaviors.
To illustrate this, we have redone the two genotype CD driving results from main text Fig. 2 using time-varying
N(t). All parameters are as described in Methods Sec. 4.4, except that N(t) varies with the control parameter
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Figure S2. The KL divergence between the actual and IE genotype frequency distributions for the M = 2 system
described in Methods Sec. 4.4, calculated using numerical solutions to the Fokker-Planck equation. The dashed
curve shows the results of the original protocol, while the colored curves show deliberately inaccurate CD protocols:
the mutation rates that enter into the CD solution of Methods Eq. (20) are scaled by a factor c to mimic
experimental measurement errors, where c= 1 corresponds to the true CD protocol. Six different inaccurate
protocols are shown, with c ranging from 0.1 to 10.
according to: N(t) =N0(1 + ζs1(λ(t))), where N0 = 104 and ζ is a constant. The original two genotype results for
constant N are recovered when ζ = 0. Fig. S1A shows five forms for N(t) for different ζ, and Fig. S1B shows the
corresponding driving results, calculated using numerical solutions of the Fokker-Planck dynamics (main text Eq. (1)).
The dashed curves show the Kullback-Leibler divergence between the IE and actual genotype frequency distributions
using the original protocol, and the solid curves using the approximate CD protocol (which is independent of N(t)).
In all cases CD driving dramatically reduces lag, improving the agreement between IE and actual distributions: the
KL divergences under CD remain below 1 bit throughout the whole protocol, in contrast to the original cases where
the divergence peaks above 10 bits.
F Robustness of counterdiabatic driving to errors in the protocol
In the main text we explored one way in which counterdiabatic driving may still be effective even in scenarios where
precise implementation of the protocol described by main text Eq. (4) is hampered by practical constraints. In the
M = 16 example direct realization of the full s˜(λ(t),
.
λ(t)) solution is constrained by the fact that there is one control
variable (drug concentration) and this control variable may have a limited range (no larger than a certain maximum
allowable dosage). However we showed protocols that approximate the CD solution could still produce excellent
results in terms of driving the system near the desired trajectory of genotype distributions over finite times.
Here we look at another potential hindrance: what if there were errors in the quantities we use to calculate
CD driving via main text Eq. (4)? The latter involves the mean IE genotypes frequencies x(λ(t)) and selection
coefficients s(λ(t)) in the original protocol as a function of the control parameter. Using the moment relationship
of Eq. (S39), x(λ(t)) can in turn be calculated with knowledge of the mutation rate matrix m and s(λ(t)). We
can imagine different potential sources of error: i) One possibility is that our estimate for s(λ(t)) of the original
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protocol contains some inaccuracies. For example, in the case where the control parameter is a drug concentration,
the genotype fitness versus drug dosage curve from earlier experiments might have measurement artifacts. Assuming
that we had a good estimate of the mutation rates mµν , we could still calculate the correct x(λ(t)) associated with
each value of our s(λ(t)) trajectory through Eq. (S39). Hence main text Eq. (4) would still yield a valid CD protocol,
in the sense that the system would be approximately guided through a series of IE distributions corresponding
to s(λ(t)), assuming we could implement the calculated s˜(λ(t),
.
λ(t)). It would not be precisely the series of IE
distributions actually associated with λ(t), but nevertheless Eq. (4) would still provide a recipe for following a path
in the space of IE distributions. ii) Another possibility is that our estimate for the mutation rates mµν is flawed.
This would propagate into errors in our calculation of x(λ(t)) associated with s(λ(t)). Because of these errors the
results of Eq. (4) would no longer necessarily be a CD protocol for s(λ(t)).
To understand the effects of errors in the mutation rates, we investigated the M = 2 example with deliberately
inaccurate protocols. For M = 2 the expression for the mean genotype frequency x1(λ(t)) is given by Methods
Eq. (19), which in turn yields the CD protocol solution in Methods Eq. (20). We modified the protocol by scaling
the mutation rates in Eq. (20) by a factor of c, so m12 =m21 = cµ0, where µ0 = 2.5×10−3 is the actual mutation
rate of the M = 2 system. All other parameters as described in Methods Sec. 4.4. The value c= 1 corresponds to
the true CD protocol, while other values correspond to inaccurate protocols. As seen in main text Fig. 2D, the true
CD protocol works effectively at all times, with the KL divergence between the IE and actual genotype distributions
getting no larger than about 0.02 bits. In contrast, the original protocol leads to severe lag at intermediate times,
with the KL divergence peaking around 17 bits. Fig. S2 shows KL divergence results for inaccurate protocols, with c
ranging from 0.1 to 10, calculated using a numerical Fokker-Planck approach. As expected, we see a breakdown
of CD driving, with the IE and actual distributions differing dramatically at intermediate times. For the most
inaccurate protocols, at c= 0.1 and c= 10, the peaks in the KL divergence are comparable to or greater than those
without CD. However milder errors, like c= 0.5 and c= 2, perform much better than the original protocol, with the
divergence peaking around 2 bits.
There is one silver lining in the error analysis: even though we lose a degree of control over the genotype
distributions at intermediate times (they no longer follow precisely the desired series of IE distributions over time),
we still retain some benefits in arriving at our destination faster. All the inaccurate protocols analyzed, particularly
those where the mutation rates were underestimated (c < 1) showed faster convergence to the final equilibrium
distribution at long times (i.e. faster decay of the KL divergence) than the original protocol (dashed curve in Fig. S2).
Thus some practical benefit of the calculated protocol remains for errors up to an order of magnitude in the mutation
rates. Clearly having as good an estimate as possible of the mutation rates is beneficial for complete control, but the
approach has some tolerance for the inevitable inaccuracies that will enter into experimentally estimated system
parameters.
G Mapping the agent-based model to a Fokker-Planck equation
In order to derive the mapping summarized in Methods Sec. 4.5.3, the first step is describing the dynamics of the
agent-based model (ABM) over each time step in terms of a chemical Langevin equation57. This in turns allows us
to map the ABM to an effective Fokker-Planck equation, using the standard relationship between Langevin and
Fokker-Planck dynamics55. At simulation time step τ we have nµ(τ) organisms with genotype µ, and the ABM
code will update this to nµ(τ + 1) at the next time step. So long as we are interested in time scales much larger
than a single simulation time step, and the updates per step are small compared to nµ(τ) 1, we can treat nµ(τ)
as a continuous population variable and τ as a continuous time variable, so that nµ(τ + 1)−nµ(τ)≈ dnµ(τ)/dτ . In
this continuum description, the rate of change dnµ(τ)/dτ will be related to a series of stochastic “reactions”, which
we will label with an index k = 1, . . . ,R, where R is the total number of possible reactions. Each reaction represents
an aspect of the code that contributes to changes in the genotype populations. The amount by which the population
of genotype µ changes in the kth reaction is denoted as ∆kµ, and the probability of this reaction occurring at time
step τ is pik(τ). The corresponding chemical Langevin approximation describing the change in the population of
genotype µ is given by57:
dnµ
dτ
=
R∑
k=1
∆kµpik(τ) +
R∑
k=1
∆kµ
√
pik(τ)Γk(τ). (S44)
Note that throughout this section we will not be using the Einstein summation convention, so all sums will be
explicitly indicated. The first term represents the deterministic contribution of all the reactions, while the second
term is the corresponding noise introduced by the stochasticity of the reactions. The Γk(τ) functions are independent
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Gaussian white noise functions with zero mean that satisfy 〈Γk(τ)Γk′(τ ′)〉= δkk′δ(τ − τ ′). The average 〈 〉 is taken
over an ensemble of realizations of the system (i.e. an ensemble of simulation trajectories).
To complete the Langevin description, we have to identify ∆kµ and pik(τ) for each reaction. Based on the ABM
procedure described in Methods Sec. 4.5.3, we can enumerate the different types of reactions as follows:
• There are M possible cell death reactions, one for each genotype. If reaction k corresponds to the death of
a genotype µ organism, then ∆kµ = −1, ∆kν = 0 for all ν 6= µ, and pik(τ) = nµ(τ)d, where d is the death
probability at each simulation time step.
• There are M possible cell division reactions, one for each genotype. If reaction k corresponds to the division of
a genotype µ organism, then ∆kµ = 1, ∆kν = 0 for all ν 6= µ, and pik(τ) = bµ(τ)(1−d)nµ(τ). Here bµ(τ) is the
cell division probability given by Methods Eq. (21), which due to the carrying capacity in the system depends
on the current total cell population Ncell(τ) =
∑M
µ=1nµ(τ). The factor (1−d) accounts for the fact that cell
division can only occur if the cell survives the initial culling at the death step of the code.
• There are M(M −1) possible mutation reactions (assumed to occur instantaneously after the cell division
reactions) where newly born cells of one genotype mutate into a different genotype. If reaction k corresponds a
new born cell of type ν mutating into a different type µ, then ∆kµ = 1, ∆kν =−1, ∆kσ = 0 for all σ 6= µ,ν, and
pik(τ) = mˆµνbν(τ)(1−d)nν(τ) where mˆµν is the mutation probability per time step in the ABM simulation.
Thus there are altogether R=M(M +1) possible reactions. Before going further, we will narrow our focus to
the system after it reaches equilibrium at some constant set of selection coefficients si(λ). The total population
will then fluctuate around some steady state mean value Ncell =
∑M
µ=1〈nµ(τ)〉. The latter can be calculated by
summing both sides of Eq. (S44) over all µ, and then taking the mean. The result is:
0 =
M∑
µ=1
R∑
k=1
∆kµ〈pik(τ)〉=−dNcell + (1−d)
M∑
µ=1
〈bµ(τ)nµ(τ)〉. (S45)
In the second equality we have explicitly plugged in all the different possible reactions and their probabilities. From
Methods Eq. (21) we know that for Ncell(τ) < K the division probability is given by bµ(τ) = b0(1 + si(λ))(1−
Ncell(τ)/K). For simplicity, let us ignore Ncell(τ) fluctuations in this expression and write
bµ(τ)≈ b0(1 +sµ(λ))
(
1− Ncell
K
)
. (S46)
Substituting this into Eq. (S45) we get:
0≈−dNcell + (1−d)b0
(
1− Ncell
K
) M∑
µ=1
(1 +sµ(λ))〈nµ(τ)〉. (S47)
If we make the typical assumption that |sµ(λ)|  1, then the sum on the right is approximately equal to Ncell. This
approximation still remains valid even if a subset of genotypes satisfies |sµ(λ)|  1, while the others have substantial
negative selection coefficients (as is the case for the fitness landscapes in our simulations). Then the latter group of
less fit genotypes will have negligible populations relative to the former group, and the sum will still approximately
evaluate to Ncell. Using this simplification, we can solve Eq. (S47) for Ncell:
Ncell ≈K
(
1− d
b0(1−d)
)
. (S48)
Plugging this into Eq. (S46) we find
bµ(τ)≈ (1 +sµ(λ)) d1−d . (S49)
This approximate form for bµ(τ) will prove useful below.
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In order to connect the ABM dynamics described through Eq. (S44) to our Fokker-Planck formalism, we need to
express these dynamics in terms of genotype frequencies, xµ(τ) = nµ(τ)/Ncell(τ). Using the chain rule, the derivative
of xµ(τ) with respect to τ can be written as:
dxµ(τ)
dτ
= 1
Ncell(τ)
dnµ(τ)
dτ
− nµ(τ)
N2cell(τ)
M∑
ν=1
dnν(τ)
dτ
= (1−xµ(τ))
Ncell(τ)
dnµ(τ)
dτ
− xµ(τ)
Ncell(τ)
M∑
ν 6=µ
dnν(τ)
dτ
.
(S50)
Using Eq. (S44) we can rewrite this as follows:
dxµ(τ)
dτ
= 1
Ncell(τ)
R∑
k=1
pik(τ)
(1−xµ(τ))∆kµ−xµ(τ) M∑
ν 6=µ
∆kν
+ηµ(τ)d, (S51)
where ηµ(τ) incorporates all the noise contributions,
ηµ(τ)≡ 1
Ncell(τ)d
R∑
k=1
Γk(τ)
√
pik(τ)
(1−xµ(τ))∆kµ−xµ(τ) M∑
ν 6=µ
∆kν
 . (S52)
Let us plug in the details of all the reaction types into Eq. (S51), and use Eq. (S49) for bµ(τ) to simplify. For
µ= i= 1, . . . ,M −1, we find:
dxi(τ)
dτ
=
M∑
ν 6=i
mˆiν(1 +sν(λ))xν(τ)d−
M∑
ν 6=i
mˆνi(1 +si(λ))xi(τ)d+
M−1∑
j=1
gij(x(τ))sj(λ)d+ηi(τ)d, (S53)
where g is the matrix defined in Methods Eq. (7) and we note that sM (λ) = 0 from the definition of the selection
coefficients (since genotype M is the wild type). Let us define a rescaled time t≡ τd, which allows Eq. (S53) to be
written as:
dxi(t)
dt
= vi(x(t);λ) +ηi(t), (S54)
where
vi(x(t);λ) =
M∑
ν=1
mˆiν(1 +sν(λ))xν(t)−
M∑
ν 6=i
mˆνi(1 +si(λ))xi(t) +
M−1∑
j=1
gij(x(t))sj(λ). (S55)
Using Eqs. (S52), (S49), the details of the reaction types, and the relation 〈Γk(τ)Γk′(τ ′)〉= δkk′δ(τ − τ ′), we can
write the correlations of the noise terms for i, j = 1, . . . ,M −1 as:
〈ηi(t)ηj(t′)〉= 2δ(t− t
′)
Ncell(t)
[gij(x(t)) +O(mˆ,s(λ))] . (S56)
Note that we have used the fact that Dirac delta functions change under a rescaling of variables as δ(τ−τ ′) = δ(t−t′)d.
The correction terms not explicitly shown in the bracket of Eq. (S56) involve elements of the matrix mˆ and selection
coefficient vector s(λ). Assuming mˆiµ, |si(λ)|  1, these can be ignored relative to the leading contribution gij(x(τ)),
and we will also approximate Ncell(t) ≈Ncell. Finally, since the noise functions ηi(t) have zero mean, Eq. (S56)
represents the covariance of the noise, and hence can be used to define a diffusivity matrix:
〈ηi(t)ηj(t′)〉= 2Dij(x(t))δ(t− t′), whereDij(x(t))≈ gij(x(t))
Ncell
. (S57)
Eqs. (S54)-(S55), together with the noise covariance result of Eq. (S57), constitute a system of Langevin equations
for the genotype frequencies xi(t). Using the standard relation between Langevin and Fokker-Planck equations55,
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we know that the corresponding Fokker-Planck operator has the form of Eq. (S1), with diffusivity matrix Dij(x)
defined through Eq. (S57), and the velocity function vi(x;λ) defined through Eq. (S55).
Comparing Eqs. (S55) and (S57) to the velocity and diffusivity definitions in our Wright-Fisher Fokker-Planck
formalism, main text Eq. (6), we see that they match under the mapping:
miν = mˆiν(1 +sν(λ)) forν 6= i, N = 12Ncell =
K
2
(
1− d
b0(1−d)
)
. (S58)
To derive this mapping, we have used the fact that the diagonal entries of m are defined as mαα ≡−
∑
β 6=αmβα.
H Potential future applications of CD driving in evolutionary systems
The CD driving examples in the main text and SI were based on anti-malarial drug resistance fitness data from
Refs. 2, 3. This experimental system is particularly attractive for our purposes, since it is the only one we are aware
of to date for which a full “seascape” has been measured: the set of fitnesses for all possible combinations of a
set of alleles of interest over a range of environmental conditions, i.e. drug dosages. However there are no reasons
why similar experimental techniques cannot be applied to construct seascapes for other systems. For example,
single-environment (single dosage) drug-resistance landscapes have been measured in E. coli for 16 antibiotics1, and
these could be expanded to include fitnesses across a range of drug doses along the same lines as in Ref. 2.
One incentive for measuring such seascapes would be applications of CD in the treatment of drug resistance in
infectious disease and cancer. Let us consider, for instance, a pathogen and two different drugs that can potentially
kill or hinder its growth. Prior to drug treatment the pathogen population might consist of a heterogeneous mixture
of genetic variants. With exposure to one of the drugs, that mixture changes as the pathogen mutates, with resistant
variants coming to dominate due to natural selection. However suppose that these variants resistant to the first drug
are in turn extremely susceptible to the second drug. Thus by steering of the evolution of the population by use
of the first drug, we have created a situation where the second drug can be particularly effective, improving our
chances of eradicating the disease using a two-stage sequence of drugs. Clearly for this to work the initial steering
stage has to be accomplished quickly60,61, before the overall population of resistant variants under the first drug
rebounds sufficiently to endanger the patient. The aforementioned scenario is not merely hypothetical, but describes
a phenomenon known as “collateral sensitivity” between the pathogen and the two drugs in question. It has been
observed in vitro and in clinical isolates for a variety of infectious diseases, as well as cancer62,63. Theoretical and
experimental work has demonstrated the prevalence of this phenomenon and the potential for carefully crafted drug
sequences to exploit this relationship7,34,64–67. However a key question in applying such a strategy clinically is
how long it would take for the “steering” stage under the first drug to be completed, achieving the desired target
distribution of genetic variants ready for the application of the second drug60,61,68,69. Given the slow nature of
evolution, having the first stage drag out into weeks or months would severely limit the clinical usefulness of this
approach. CD speed-up could be useful in overcoming this challenge, by providing a dosage protocol to hasten
arrival at the target distribution. This could be one of the key steps in translating this theoretical treatment idea
into a clinically actionable therapeutic strategy.
There are also systems outside the context of evolutionary medicine where we expect this protocol to be useful
despite the required seascape details. In the context of agriculture, CD driving could potentially be used to speed of
up the process of crop breeding. As in E. coli, fitness landscapes have been successfully measured in maize70,71,
although not full seascapes. Note that these are technically trait-yield landscapes rather than true fitness landscapes,
but that by performing artificial selection based on yield we can effectively use them as fitness landscapes. Of course,
if we had sufficient information to use CD driving on a crop, we would also have sufficient information to use genetic
engineering instead. It is unclear whether it would ever be advantageous to use CD driving over genetic engineering,
but we suspect instances exist where it would be (perhaps due to CD diving’s ability to act on an entire population
at once, or due to anti-GMO sentiment). A similar argument holds for the potential applicability of CD driving to
synthetic biology.
Measuring seascapes in additional systems would be labor-intensive, but tractable if it were the only obstacle
standing between us and substantial advances in applications like those mentioned above. If there do exist cases
where collecting such full seascapes may be prohibitively difficult, we can try the alternative strategy described in the
Discussion section of the main text: quasi-adiabatic in vitro experimental trials where we vary external parameters
(i.e. drug dosages) extremely gradually, and use sequencing at regular intervals to determine the quasi-equilibrium
mean genotype fractions as a function of dosage. This would be generally faster than trying to determine the
fitnesses of each genotype at each dosage level, and would provide enough information to construct our CD protocol
through Eq. (4) of the main text.
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I Generality of the CD approach: deriving approximate protocols in additional landscape
examples
For the empirical seascape used in the main text, describing the response of 16 genotypes to the anti-malarial drug
pyrimethamine2,3, we noted that two of those genotypes dominate at different times during the driving: initially
at small concentrations the genotype 1110 (i= 15) has the largest population, but is eventually overtaken by the
wild-type genotype 1111 (i = 16) at large concentrations as the drug is ramped up. This allowed a particularly
simple approach to approximate the CD protocol of main text Eq. (4) by focusing on the the selection coefficient s15
that describes the relative fitness of 1110 versus 1111: at every time step we numerically find the drug concentration
λ˜(t) where the corresponding selection coefficient s15(λ˜(t)) is closest to the value of the CD solution s˜15(λ(t), λ˙(t))
from Eq. (4), with the constraint that λ˜(t) must be lower than a certain maximum cutoff λ˜max. This approximate
CD dosage protocol λ˜(t) is compared to the original dosage protocol λ(t) in main text Fig. 3E for different cutoffs
λ˜max. While we saw the resulting CD driving worked quite well for this example, how would we generalize this
approach to more complex scenarios?
In this section we describe such a general approach for finding the set of experimental control parameters λ˜(t)
that best approximates main text Eq. (4) given an arbitrary seascape. We show how the two-genotype approximation
described above is a special case of this general approach, and illustrate the latter through two additional driving
examples: one using a modified version of the pyrimethamine seascape, and the other using the empirical seascape
for cycloguanil, another anti-malarial drug2. In both of these cases driving takes us through three different regimes,
with different genotypes dominating in each regime.
Let us start with Eq. (18) of the Methods,
∂tx(λ(t)) = g
(
x(λ(t))
)
δs˜
(
λ(t),
.
λ(t)
)
= g
(
x(λ(t))
)(
s˜
(
λ(t),
.
λ(t)
)−s(λ(t))) . (S59)
The CD solution s˜
(
λ(t),
.
λ(t)
)
to this equation is shown in main text Eq. (4). Now let us imagine we want to use the
control parameters accessible to us and implement a protocol λ˜(t) that approximates this CD solution. To do this,
let us replace s˜
(
λ(t),
.
λ(t)
)
with s(λ˜(t)) on the right-hand side of Eq. (S59). Subtracting the left and right-hand
sides of the resulting equation from each other, and squaring the difference, gives us the following loss function:
L(λ˜(t)) =
[
∂tx(λ(t))−g
(
x(λ(t))
)(
s
(
λ˜(t)
)−s(λ(t)))]2 . (S60)
If we could find a λ˜(t) such that L(λ˜(t)) = 0 at all t then we would have exactly implemented the CD solution of
main text Eq. (4). However in practice the control parameters λ˜(t) that we can externally manipulate may not allow
this to be perfectly satisfied. Hence we do the next best thing and find λ˜(t) that minimizes the loss function. Note
that the loss function can also be rewritten in the following form, where we substitute in the right-hand side of
Eq. (S59) for ∂tx(λ(t)):
L(λ˜(t)) =
[
g
(
x(λ(t))
)(
s˜
(
λ(t),
.
λ(t)
)−s(λ(t)))−g(x(λ(t)))(s(λ˜(t))−s(λ(t)))]2
=
[
g
(
x(λ(t))
)(
s˜
(
λ(t),
.
λ(t)
)−s(λ˜(t)))]2 . (S61)
In this form we can explicitly see that minimizing the loss function is the same as minimizing the difference between
s˜
(
λ(t),
.
λ(t)
)
from main text Eq. (4) and the experimentally accessible selection coefficient trajectory s
(
λ˜(t)
)
. This
difference is weighted by the response matrix g
(
x(λ(t))
)
, which governs how much each component of the selection
coefficient contributes to the velocity term in the Fokker-Planck equation through Methods Eq. (6). This is not
the only possible form of the loss function (one can imagine alternative ways of weighting the selection coefficient
differences) but in the numerical examples we investigated this form gave us the best driving results.
Minimizing Eq. (S61) (or equivalently Eq. (S60)) to find λ˜(t) is a general prescription for getting an approximate
CD protocol, regardless of the system. How well that protocol will work (how close we can get to true CD driving)
is of course a system-specific question, which will depend on the nature and number of control parameters that we
can vary and the ranges they can explore (the dimensionality and extent of the space of possible λ˜(t) curves). In
general we expect that the more degrees of freedom we have for λ˜(t), the closer we can approach the CD solution.
Because simultaneously controlling a large number of parameters is experimentally more challenging, in practice one
will seek out the smallest number that can still give a reasonable approximation to CD driving.
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Figure S3. Comparison of the original drug dosage λ(t) (blue curve) for the pyrimethamine seascape example of the
main text versus the approximate CD dosage protocol λ˜(t) calculated using two methods: minimizing the full loss
function L(λ˜(t)) of Eq. (S61) (green curve) versus minimzing the simplified loss function Lpyr(λ˜(t)) of Eq. (S62)
(dashed red curve).
To get some intuition into this approximation scheme, let us consider several examples. For the pyrimethamine
seascape used in the main text, minimizing Eq. (S61) turns out to be nearly the same as minimizing the simpler
alternative loss function that involves only the i= 15 selection coefficient component:
Lpyr(λ˜(t)) =
(
s˜15
(
λ(t),
.
λ(t)
)−s15(λ˜(t)))2 . (S62)
This is because i= 15 difference makes the major contribution to the right-hand side of Eq. (S61), given that the
1110 and 1111 genotypes dominate the population at different stages of the driving. Fig S3 shows the drug protocol
λ˜(t) calculated by minimizing Eq. (S61) versus that found from minimizing the simpler loss function of Eq. (S62).
The two are nearly identical throughout the entire time range. As can be seen in main text Fig. 3, for this system a
single control parameter (pyrimethamine drug dosage) is sufficient to get an excellent approximation to the CD
protocol over the entire time range. The genotype distributions under the protocol, p(x, t), are kept close to the
IE target distributions ρ(x;λ(t)), measured via their KL divergence (main text Fig. 3F). Since the distributions
are narrow for the large N case, an individual simulation trajectory (solid curves in main text Fig. 3C) will closely
follow the mean IE genotype frequencies x
(
λ(t)
)
(dashed curves in main text Fig. 3C). The excellent performance
of the approximate CD protocol in this case likely stems from the fact that the loss function is dominated by a
single component (i= 15), and varying a one-dimensional control parameter allows us to effectively minimize this
component.
Let us now make the situation more complicated in the following way. Take the same pyrimethamine seascape,
based on the empirical data of Ref. 2, and make a single parameter alteration: increase the base growth rate (at
zero drug concentration) of genotype 0110 by 5%. Everything else in the system remains the same. Under the
original drug protocol (blue curve in Fig. S4C) the mean IE genotype fractions (dashed curves in Fig. S4A,B) show
a more complex behavior over time: 0110 dominates at small times, followed by a period of 1110 domination, until
at large times 1111 takes the lead. As time is varied there are now multiple components on the right-hand side of
Eq. (S61) that shift in their relative significance. The result of minimizing L(λ˜(t)) is the approximate CD protocol
λ˜(t) shown in green in Fig. S4C. This now has two dosage peaks, one around the 0110-1110 transition and the
other around the 1110-1111 transition. Under the original protocol the simulation trajectory lags behind the IE
expectation (Fig. S4A), but with the approximate CD driving this lag is largely eliminated (Fig. S4B). The overall
reduction in lag time (quantified as described in Methods Sec. 4.5.4) is ∆t= 1128 generations, comparable to the
reduction achieved in the main text example. Note however that the agreement between simulation and IE curves
during the 1110-dominated regime is only partial. Clearly, manipulating a single control parameter (pyrimethamine
dosage) is not sufficient to achieve a close enough approximation to the CD protocol to get fine-grained control
in this regime. The drug dosage peak near generation 400 is sufficient to drive the interchange between 0110 and
1110, but as a side-effect causes the overshoot of 1111 with respect to its IE expectation. However this overshoot is
34/36
0110
0111
1110
1111
0110
0111
1110
1111
A
B
C
D
Figure S4. CD driving for an altered 16-genotype pyrimethamine seascape. This is the same seascape as
in main text Fig. 3, using the experimental data of Ref. 2, except that genotype 0110 has been modified to have a
5% larger base growth rate under no drug conditions. (A,B) Sample simulation trajectories (solid lines) versus IE
expectation (dashed lines) for the fraction of 4 representative genotypes without (A) and with (B) CD driving.
The CD driving is implemented approximately through the drug dosage protocol (green curve) shown in panel (C)
with cutoff 10−2 M. The original protocol (blue curve) is shown for comparison. (D) Kullback-Leibler divergence
between actual and IE distributions versus time, with and without CD driving.
resolved quickly as 1111 approaches its IE curve, and the subsequent driving pushes the system toward the final
IE values with little delay. Thus if one were interested only in getting to the final target distribution of genotypes
quickly (likely the most common real-world application), this approximate CD protocol would suffice. On the other
hand there could be situations where following the exact IE path through genotype space at all times was important,
for example if we wanted to steer the system away from problematic intermediate genotypes in some evolutionary
medicine scenario. In this case we could benefit from having additional control knobs. For example the possibility of
using a second drug alongside pyrimethamine might allow for a better CD approximation.
Fig. S5 tells a qualitatively similar story to Fig. S4, but using the seascape from cycloguanil, a different
anti-malarial drug. The cycloguanil data was also experimentally measured in Ref. 2, and we do not make any
modifications to the empirical values. We choose an original dosage protocol λ(t) with the same form as before
(Methods Eq. (22)), but with saturating dosage parameter a = 1.1× 10−5 M. Under this protocol, we see three
regimes during the driving, but in a different combination from the previous example: the dominance shifts from
1110 to 0110 to 0111 as the drug is increased. Again the approximate CD protocol involves two dosage peaks, and
gets us to the final target distribution with less lag than the original protocol (∆t= 373 generations). Though we
currently only have data in this system for one drug applied at any given time, we see that despite this limitation
we can still do a fairly decent job of eliminating lag, whether that drug be pyrimethamine or cycloguanil. The
imperfect control during the intermediate regime could potentially be resolved by a protocol that involves both drugs
applied simultaneously (or another external intervention). Thus, while our theory provides the basic framework to
understand CD driving in such evolutionary systems, there are a variety of pragmatic questions about balancing
driving accuracy versus the complexity of the control protocol that will provide interesting subjects for future work.
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Figure S5. CD driving for a 16-genotype cycloguanil seascape. This is the same 16-genotype system as in
the examples of main text Fig. 3 and Fig. S4, except using the anti-malarial drug cycloguanil instead of
pyrimethamine. The seascape is based on the experimental data of Ref. 2, without any modifications. (A,B)
Sample simulation trajectories (solid lines) versus IE expectation (dashed lines) for the fraction of 4 representative
genotypes without (A) and with (B) CD driving. The CD driving is implemented approximately through the drug
dosage protocol (green curve) shown in panel (C). The original protocol (blue curve) is shown for comparison. (D)
Kullback-Leibler divergence between actual and IE distributions versus time, with and without CD driving.
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